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Outline
The main body of this thesis is split into two parts. Part I deals with a mathematical model
for nanoparticles growth in solution. Part II analyses mathematical and physical aspects of
magnetic drug targeting. Chapter 1 is a general introduction to those topics. Chapter 2 is
an overview of the classical techniques to solve a particular Stefan problem related to the
one studied in the first part of the thesis. Chapter 3 analyses the standard model for the
growth of a single particle in solution. Chapter 4 presents an extended version of the same
model for a system of N nanoparticles. Chapter 5 deals with the mathematical modelling
of nanodrug delivery. Chapter 6 contains the conclusions.
The list below include the publications derived from this thesis. From 1 to 3, correspond
to Chapters 3, 4 and 5, respectively.
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Abstract
It is well-known that many properties of nanoparticles, such as luminescence,
photostability, optical radiation efficiencies and electric properties, are size dependent.
Hence, the ability to create nanoparticles of a specific size is crucial. In this thesis, we
begin by developing mathematical models for the nanoparticle growth process and so
obtain guidelines for efficient growth strategies. Once the growth process is understood we
move on to a specific practical application of nanoparticles, namely targeted drug delivery.
In the first part, the mathematical model analysed is a non-standard Stefan problem
where the moving boundary is the surface of the particles. In the second part, the model
involves the motion of a non-Newtonian nanofluid subject to an external magnetic field
and an advection-diffusion equation for the concentration of the nanoparticles in the fluid.
In both cases we employ several mathematical tools, such as similarity solutions,
asymptotic analysis and numerical techniques.
In Chapter 2 we work on a simple but representative Stefan problem with constant
boundary values by means of analytical and numerical methods in order to identify the
key mathematical aspects of this type of problem. In Chapter 3 the standard model for
the growth of a single nanoparticle in solution is presented and analysed using the
techniques developed in the previous chapter. Particular attention is paid to the validity
of the assumptions regularly made in literature. Specifically, the analysis of the diffusion
boundary layer shows how the standard model does not hold at early times, while the
pseudo-steady assumption is found to be valid. Moreover, within experimental error a new
analytical solution for the particles radius depending only on two independent parameters
is determined. This demonstrates that the model is unable to distinguish between
diffusion and reaction driven growth. In Chapter 4 the model of Chapter 3 is extended for
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xa system of N particles, where N is arbitrarily large. By non-dimensionalising the system
and identifying dominant terms, the problem is reduced and solved by analytical and
numerical techniques. The Gibbs-Thompson equation for the solubility of the particles
shows the importance of this effect in order to control Ostwald ripening, which is driven
by the delicate balance between the bulk concentration and the particles solubility. The
comparison with experimental data and the analytical solution found in the previous
chapter shows excellent agreement, giving an important tool to control the particle size
distribution and optimise strategies for the growth.
The second part of the thesis deals with a practical use of nanoparticles, the promising
medical technique of magnetic drug targeting. In Chapter 5 a mathematical model for the
transport of drug nanocarriers in the bloodstream under the influence of an external
magnetic field is presented. Simplifications of the geometry allows the reduction of the
Navier-Stokes equations for the blood flow. Within the restrictions of these simplifications
analytical solutions are obtained. The comparison between the Newtonian and
non-Newtonian approximations shows the importance of taking into account the
shear-thinning behaviour of the blood when modelling drug delivery. In this scenario, the
viscosity of the blood, which changes depending on the shear rate, is crucial in the
calculation of the velocity of the magnetic particles in the vessel and non-Newtonian
models need to be used. The ultimate goal is to determine strategies to maximise drug
delivery to a specific site.
Resumen
Es conocido que muchas propiedades de las nanopartículas, como la luminiscencia, la
fotoestabilidad, la eficiencia de la radiación óptica y las propiedades eléctricas, dependen
del tamaño. Por lo tanto, la capacidad de crear nanopartículas de un tamaño específico es
crucial. En esta tesis, desarrollamos modelos matemáticos para el proceso de crecimiento
de nanopartículas con el objetivo de obtener pautas para estrategias de crecimiento
eficientes. Una vez comprendido el proceso de crecimiento, analizamos una aplicación
práctica de las nanopartículas, conocida como la liberación controlada de fármacos. En la
primera parte, el modelo matemático analizado es un problema no estándar de Stefan
donde la frontera libre es la superficie de las partículas. En la segunda parte, tratamos un
modelo para el movimiento de un nanofluido no newtoniano sujeto a un campo magnético
externo y una ecuación de advección-difusión para la concentración de las nanopartículas
en el fluido. En ambos casos empleamos varias herramientas matemáticas, como variables
de similitud, análisis asintótica y métodos numéricos.
En el Capítulo 2 analizamos un problema de Stefan con valores constantes en la frontera
mediante métodos analíticos y numéricos para identificar los aspectos matemáticos clave de
este tipo de problema. En el Capítulo 3 se presenta y analiza el modelo estándar para
el crecimiento de una sola nanopartícula en una solución líquida utilizando las técnicas
desarrolladas en el capítulo anterior. Se presta especial atención a la validez de las hipótesis
que se hacen regularmente en la literatura. Específicamente, el análisis de la capa límite de
difusión muestra como el modelo estándar no se cumple para tiempos pequeños, mientras
que la hipótesis de estado pseudoestable es válida. Además, se obtiene una nueva solución
analítica para la evolución del radio de la partícula que solo depende de dos parámetros
independientes. Esta solución demuestra que el modelo no puede distinguir entre la difusión
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y el crecimiento impulsado por la reacción. En el Capítulo 4, el modelo del Capítulo
3 se extiende para un sistema de N partículas, donde N es arbitrariamente grande. A
través de la adimensionalización del sistema e identificación de los términos dominantes,
el problema se reduce y se resuelve mediante técnicas analíticas y numéricas. La ecuación
de Gibbs-Thompson para la solubilidad de las partículas muestra la importancia de este
efecto para controlar la maduración de Ostwald, que es impulsada por el delicado equilibrio
entre la concentración de la solución lejos de la superficie y la solubilidad de las partículas.
La comparación con los datos experimentales y con la solución analítica encontrada en
el capítulo anterior muestra excelente resultado, dando una herramienta importante para
controlar la distribución del tamaño de las partículas y optimizar las estrategias para el
crecimiento.
La segunda parte de la tesis trata sobre un uso práctico de las nanopartículas: la
liberación de fármacos controlada. En el Capítulo 5 se presenta un modelo matemático
para el transporte de nanopartículas portadoras de fármacos en el vaso sanguíneo bajo la
influencia de un campo magnético externo. Las simplificaciones geométricas realizadas
permiten reducir las ecuaciones de Navier-Stokes para el flujo sanguíneo y encontrar
soluciones analíticas válidas dentro de los límites establecidos por dichas simplificaciones.
La comparación entre los modelos newtonianos y no newtonianos muestra la importancia
de tener en cuenta la reología pseudoplástica de la sangre a la hora de modelar la
administración de fármacos. En este escenario, la viscosidad de la sangre, que cambia en
función de la velocidad de corte, es crucial en el cálculo de la velocidad de las partículas
magnéticas en el vaso sanguíneo y es necesario utilizar modelos no newtonianos.
Finalmente, a partir del modelo formulado se establecen estrategias para maximizar la
liberación de medicamentos en un sitio específico.
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1 | Introduction
During the last decades it has been shown that nanotechnology-based industry can develop
materials, devices and systems that will change the way to work and manage scientific
challenges in a wide range of applications, like biomedicine [41, 42], environmental-related
problems [1], electronics and catalysis [9, 11, 26]. The formal definition of nanomaterials
requires the material to be man-made and with dimensions between 1 and 100 nanometers
(nm). But why is nanoscale so interesting? Nanoparticles (NPs) have unique properties
that naturally occur at that scale. There are two main features that show the power of
nanoscale:
1. Surface area to volume ratio:
Materials made up of nanoparticles have a greater surface area when compared to
the same volume of material made up of larger particles. This means that a great
amount of the material can come into contact with surrounding materials, increasing
the reactivity.
2. “Tunability” of properties:
With slight changes in size, a scientist is able to control and adapt a nanomaterial
property, such as electronic and optical properties of metals and semiconductors [74],
luminescence and photostability [46, 54], and optical radiation efficiencies [105], among
others.
Since many of these properties are size dependent, the ability to create nanoparticles of a
specific size is crucial.
A famous example that shows the great potential of this scale involves gold nanoparticles.
At the nanoscale, the motion of the gold’s electrons is confined and, because of that, they
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react differently with light compared at a larger scale. The result is that gold nanoparticles
are not yellow as we expect, but can appear red or purple according to their size. Moreover,
adjusting their dimensions, gold nanoparticles can be tuned according to the purpose: for
example, they can selectively accumulate in tumours in order to identify diseased cells and
to target laser destruction of the tumour avoiding healthy cells.
This thesis is devoted to providing a greater understanding of certain nanoscale
processes. In the first part the growth of nanoparticles is studied, with the aim of
providing guidelines for improving and optimising the process. In the second part a
specific applications for nanoparticles is considered. Specifically, the targeted delivery of
magnetic nanoparticles is modelled.
Over the past 40 years, growing nanoparticles to a specific size has been the object of
several studies. It is known that they can be prepared by both gas phase and solution
based synthesis techniques. Although the first method can produce large quantities of
nanoparticles, agglomeration and nonuniformity in particle size and shape are typical
problems [69]. Using the precipitation method monodisperse spherical nanoparticles can
be generated. The standard approach is to apply the classical La Mer and Dinegar
synthesis strategy where nucleation and growth are separated [58, 59]. The strategy is to
rapidly add the precursor at high temperature into batch reactors, causing a short
nucleation burst in order to create a large number of nuclei in a short space of time. To
separate the nucleation from growth, the reactor is cooled and the nanoparticles formed
start to grow [119]. The subsequent growth involves two different stages:
1. The focusing period, where particles increases rapidly and the size distribution is
relatively small.
2. The defocusing period, where the growth slows down and the size distribution become
larger.
The first phase leads to the desired result of monodisperse nanoparticles. In the second
phase we can observe a phenomenon called Ostwald ripening (OR), a process by which
larger particles grow at the expense of the smaller ones which dissolve due to their much
higher solubility. This process, schematized in Figure 1.1, produces monomer, which is
subsequently used to support growth of the larger particles. However, this simultaneous
3Figure 1.1: Sketch of Ostwald ripening in the case of two particles with different radius.
growth and dissolution leads to the unwanted defocusing of the particle size distribution
(PSD).
Recently, it has been shown that the PSD can be refocused by changing the reaction
kinetics. For example, in Figure 1.2, we can see a series of snapshots of the growth process of
gold nanoparticles from Bastús et al. [10], where temperature, gold precursor to seed particle
concentration, and pH are adjusted during the process in order to obtain the desired result.
The project studied in the first part of this thesis is motivated by the desire for a deeper
understanding of nanoparticles synthesis. This is motived by the work of the Inorganic
Nanoparticles group research from the Institut Català de Nanociència i Nanotecnologia
(ICN2), where the main authors of [10] worked.
Figure 1.2: Microscopy images of the growth of gold seed particles at different time steps from
Bastús et al. [10].
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In order to model this process, it will be shown how, from a mathematical point of
view, the growth of single nanoparticle is analogous to a one-phase Stefan problem. This
is a particular kind of boundary value problem for a partial differential equation where the
position of the border is time-dependent and has to be found as an unknown variable of
the system. In literature the equation that defines this position, commonly known as the
Stefan condition, usually describes the temperature distribution under a phase-change but
it is found to be perfectly suitable to define the growth evolution. To help understand this
complex nanoparticles growth problem, in Chapter 2 several analytical and numerical
techniques for solving a related Stefan problem are summarized and compared.
Simplifications are made in order to obtain analytical solutions and anticipate the
behaviour of the concentration of particles in a solution-based synthesis. However, there
exist very few practically useful exact solutions to moving boundary problems and so
other types of approximations will be studied, such as perturbation techniques, the heat
balance integral method and its improvements, and finally numerical methods.
Chapter 3 is dedicated to the correct interpretation of the standard model for the growth
of a single spherical particle and has already been published [79]. The main results concern
the limited time-range for the validity of this model and the impossibility to distinguish
between diffusion or surface reaction driven growth in the pseudo-steady approximation.
Moreover, an explicit equation for the growth of the particle radius is given which is shown
to depend only on two independent parameters. Finally, the importance of the variation of
particle solubility is highlighted, especially during the initial phase of the growth.
The single particle model may be adapted to approximate the evolution of the average
radius of a group of similar sized nanoaparticles. However, in order to understand and
control the undesired Ostwald ripening we need to keep track of the radius of each particle.
For this reason, an N particle model will be developed and described in Chapter 4. This
model incorporates the particle solubility variation which then permits the model to capture
OR. The N = 2 model can equally well represent the average radii for an initially bimodal
distribution of nanocrystals while an N > 2 model can represent a much larger distribution
of particles. This work has been already accepted and is pending printing [29].
In order to show a practical use of the ability to control the size of nanoparticles,
it is interesting to introduce some applications in the field of biomedicine. Many medical
5researchers are facing a wide variety of challenges, including the detection of disease-specific
biomarkers in the blood, targeted magnetic resonance imaging contrast agents in the field
of neurological surgeries, the specific detection of DNA and proteins, and many others [31].
For example, as already mentioned above, gold nanoparticles can be precisely built in order
to selectively activate through tissue irradiation for therapeutic thermal ablation. In Figure
1.3 we can see in vivo images of intracellular labelling of tumour cells by quantum dots from
the experimental work of [114]. A precise map of the distribution of many molecular markers
can be generated by irradiation, conjugating each colour (i.e. each size) of nanoparticles with
antibodies to different molecular targets. However, it is recognized that novel mathematical
models are needed in order to secure the added value of nanotechnology into the medical
field [31].
Figure 1.3: In vivo images of intracellular labelling of tumour cells by semiconductor nanocrystals
quantum dots of different sizes from [114].
After understanding the growth process of nanoparticles, the aim of the second part of
this thesis is to look at a practical use for NPs. Specifically, a model is developed for a
very popular and effective way to introduce drugs in selected parts of human body in the
context of cancer therapy: magnetic drug targeting. This technique consist in attaching a
drug to a biocompatible magnetic nanoparticle carrier, injecting them into the circulatory
system and then using a high gradient magnetic field to direct them to the target region.
One of the great potentials of selectively reaching the desired targets is to avoid, or at least
reduce, collateral damage. Currently, the main approaches for cancer treatment are non-
specific and their efficacy is low. The technique of magnetically targeted drug delivery will
allow to deliver the drugs directly to the tumour cells which results in minimizing the doses
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required and, especially, avoiding undesired side effects. The main advantages of magnetic
nanoparticles lies on two fundamental aspects: firstly, their controllable size are smaller
than or comparable to some important biological entities, like genes, cells, proteins or virus,
and therefore adapt to interact with them; secondly, they respond to external manipulation
such as magnetic fields making them easy to transport or heat up from a distance. However,
the success of the therapy also depends of many physical aspects, such as hydrodynamic
and physiological parameters. In fact, controlling the balance between magnetic and blood
drag forces is one of the main difficulties of this technique.
The movement and directing of magnetic nanoparticles in specific vessels of the
circulatory system subject to an external magnetic field is the focus of Chapter 5. The
goal is to investigate the evolution of the physical situation taking into account all the
forces acting on the drug carriers. The mathematical model consists of a system of
nonlinear partial differential equations formed by the Navier-Stokes equations for the flow
of the blood coupled with an advection–diffusion equation for the concentration of
nanoparticles. It is important to notice that blood is a biological fluid that reaches the
whole body and understanding its rheological and flow properties is essential in order to
develop tools to handle the great majority of the diseases. Its composition results in
non-Newtonian characteristics which can affect drastically the particle dynamics.
Geometry simplifications of the chosen vessel permit the comparison between several
models for the velocity and the viscosity of the fluid, highlighting the importance to
choose an accurate approximation. Once obtained the profile for the flow of the blood, the
equation for the concentration of magnetic nanoparticles is analysed and solved by
numerical techniques. The main results concern the ability to understand whether the
magnetic force can compete with drag force when considering a correct approximation for
the viscosity of the blood.
Part I
Nanoparticle growth
7

2 | Moving boundary problems:
analytical and numerical
techniques
2.1 Introduction
Many real-life problems in the area of applied science lead to a partial differential equation
coupled with a moving boundary condition, such as the melting of ice, alloy solidification,
freezing of soil, ablation, oxygen diffusion and many others. The classical formulation of
these type of problems was introduced by Josef Stefan in 1889 (and named after him) and
deals with the phenomenon of solid-liquid change of phase [101]. In this first paper, he
modelled the growth of sea ice, solving a one dimensional diffusion equation (resulting
from conservation of heat) with a moving boundary between a polar ice cap and the
ocean. Nowadays, it is known that a lot of industrial problems can be modelled through
an adaptation of the classical Stefan theory. In the first part of this thesis we will focus on
a model for spherical nanoparticle growth in a solution, that is mathematically equivalent
to a one phase Stefan problem. The process is described by a diffusion equation for the
concentration of the solution, a Stefan condition for the evolving particle radius and a
mass conservation expression for the bulk concentration, and is a very interesting case of
these kind of problems.
The aim of this chapter is to study analytical and numerical techniques in order to solve
a related but simplified problem which may aid in the analysis of the nanoparticle growth
model. The techniques will be applied to standard configurations and then, if possible,
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adapted in subsequent chapters for the physical problem.
There are a very few practically useful exact solutions to moving boundary problems.
An exact analytical solution of the Stefan problem is possible only in a few cases even
in the one-dimensional case, and is mostly based on special type of solutions written in
terms of error and complementary error functions [47, 48]. Consequently many analytical
approximations and numerical techniques have been developed in the literature. In the next
sections, several approaches are described following the direction of the classical one phase
case. Firstly, similarity solutions and Laplace methods are used for small and large times,
to obtain expressions for the concentration and the radius of the particle [25]. Secondly,
due to the presence of a small parameter ε multiplying the time derivative in the diffusion
equation, we analyse the pseudo-steady case, which is a reasonably good approximation
of the problem as ε → 0. Assuming the dependence of the solution on this parameter, it
can be determined using a Taylor series expansion about ε = 0 where the pseudo-steady
solution appears as the first term in this expansion [49]. For this reason, perturbation
techniques have been applied to derive higher order terms to improve the accuracy of the
approximation [12, 18, 49, 55]. An interesting example of these methods applied to physical
problems can be found in [120], where it is considered the case of the solidification of a finite
slab with convective cooling and shrinkage. In cases where ε = O(1) we have employed
the Heat Balance Integral Method (from now on HBIM) to find approximate solutions to
our parabolic equation. This method was initially introduced by Goodman [43, 44] and
gained popularity due to its simplicity, although the accuracy depends on the choice of an
approximating function [73]. In 1973, Langford [60] proposed a definition of an error for
the HBIM method and later an interesting improvement has been developed and applied to
several forms of Stefan problem [72, 73, 77, 78, 80]. Finally, the solutions obtained through
the analysis are compared with numerical results via finite difference methods using the
boundary-fixing technique [37, 57].
2.2 The mathematical model
As introduced in the previous section and represented in Figure 2.1, we will analyse a
mathematical model for the growth of a single particle of radius Rˆ in a bulk solution. The
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Figure 2.1: Sketch of a particle growing in a solution.
concentration of monomer diffuses in the light grey layer of depth δ → ∞, adjusting from
cˆR to an equilibrium value equal to cˆ∞. In the limit δ →∞, the problem is then governed
by the classical diffusion equation
∂cˆ
∂tˆ
=
D
rˆ2
∂
∂rˆ
(
rˆ2
∂cˆ
∂rˆ
)
for Rˆ(tˆ) < rˆ <∞, (2.1)
describing the behaviour of the concentration cˆ(r, t) with a constant diffusion coefficient D,
and subject to the initial and boundary conditions
cˆ(Rˆ(tˆ), tˆ) = cR, tˆ > 0,
cˆ(rˆ →∞, tˆ) = c∞, tˆ > 0, (2.2)
cˆ(rˆ, 0) = c∞, Rˆ(t) < rˆ <∞,
where cR and c∞ are constant. We are interested in the location of the moving interface,
Rˆ(tˆ), which represents the particle radius. It grows due to the diffusion of the monomer
molecules from the bulk to the surface of the nanoparticles and is described by the mass
balance
dRˆ
dtˆ
= VMD
∂cˆ
∂rˆ
∣∣∣
rˆ=Rˆ(t)
, (2.3)
with the associated initial condition Rˆ(0) = R0. Note, this is equivalent to a Stefan condition
in a one-phase problem. However, the Stefan condition arises through an energy balance.
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In order to analyse the problem, we proceed to the nondimensionalisation of the
variables, then use a small time analysis and apply several methods to find approximate
and exact solutions.
The nondimensionalisation obtained using the re-scaling
c =
cˆ− c∞
c∞ − cR , r =
rˆ
R0
, t =
tˆ
τ
, (2.4)
substituting into equations (2.1) and (2.3), gives
∂c
∂t
=
τD
R20
1
r2
∂
∂r
(
r2
∂c
∂r
)
, (2.5)
dR
dt
=
τVMD (c∞ − cR)
R20
∂c
∂r
∣∣∣
r=R(t)(t)
, (2.6)
for the governing equation and the Stefan condition. Our interest about the change in time
of the moving boundary R(t) leads to choose the time scale
τ =
R20
VMD(cR − c∞) , (2.7)
and then
ε
∂c
∂t
=
1
r2
∂
∂r
(
r2
∂c
∂r
)
, (2.8)
c(R(t), t) = −1, c(∞, t) = 0, c(r, 0) = 0, (2.9)
dR
dt
=
∂c
∂r
∣∣∣
r=R(t)
, R(0) = 1, (2.10)
where the moving boundary is R = Rˆ/R0 and ε = VM (c∞ − cR). It has to be noticed that
ε is typically very small; for example in the case of the CdSe nanoparticles growth treated
in Chapters 3 and 4, the values used in [89] imply ε = O(10−3), which is a typical value in
this kind of chemical processes.
2.3 Small time analysis
Looking at the initial conditions of the problem, we can notice that although at t = 0 the
concentration is zero everywhere, as soon as the process starts we have a big jump with
c(R(t), t) = −1. This suggests that for small times we will have a large gradient for the
concentration close to the boundary. In order to understand this behaviour, we proceed
with a small time analysis applying two different methods to find the exact solution.
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2.3.1 Similarity solution method
Let t = εατ where ε  1, we analyse the behaviour at r ∼ R(t) by introducing the new
variable z defined by
r −R(t) = εβz, (2.11)
where α and β have to be found. Putting (2.11) into the governing equation (2.8), we have
ε
[
1
εα
∂c
∂τ
]
≈ 1
ε2βR2(t)
∂
∂z
(
R2(t)
∂c
∂z
)
, (2.12)
and considering z  1, equation (2.12) leads to
ε1−α+2βcτ = czz. (2.13)
We want ε1−α+2β ∼ 1, that is 1− α+ 2β = 0 . Thus, in order to look close to the border,
we choose β = 1 that gives α = 3, obtaining the classical diffusion problem described by
cτ = czz, (2.14)
and subject to the conditions
c(0, τ) = −1, c(∞, τ) = 0, c(z, 0) = 0. (2.15)
The moving boundary is governed by the differential equation
Rτ = ε
2cz|z=0 (2.16)
where R(0) = 1. Equation (2.16) shows clearly that R is small at small times.
One possible solution can be found via the similarity variables method, considering the
change of variable η = Azτα and c(r, τ) = f(η). The derivatives become
cτ = fηητ = fηαAzτ
α−1,
cz = fηηz = fηAτ
α,
czz = (cz)z = (fηηz)z = (fηAτ
α)z = (fηAτ
α)ηηz = fηηA
2τ2α.
(2.17)
Substituting (2.17) into (2.14), considering the definition of η and multiplying for τ both
terms, we will have the related equation
αηfη = A
2t2α+1fηη. (2.18)
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In order to remove the time dependence, we choose α = −1/2 and A = 1/2, and we obtain
the simple ODE
−2ηfη = fηη. (2.19)
Let y = fη, then (2.19) can be written as
−2ηy = yη, (2.20)
which can be easily solved by separation of variables, obtaining
y = C1e
−η2 . (2.21)
Applying the last change of variable, we can integrate this expression and obtain
f(η) = C1
√
pi
2
erf(η) + C2. (2.22)
The values for the constant of integration can be found using boundary conditions (2.15),
which give C1 = 2/
√
pi and C2 = −1. Therefore, coming back to the first change of variables,
the solution will be
c(z, τ) = erf
(
z
2
√
τ
)
− 1. (2.23)
Following the same idea, we can find an analytical solution for the moving interface since
we already have an expression for the concentration. Considering that
cz = fηηz =
fη
2
√
τ
, (2.24)
with the same change of variables, (2.16) becomes
Rτ =
ε2
2
√
τ
fη|η=0 = ε
2
2
√
τ
(
2√
pi
e−η
2
) ∣∣∣
η=0
=
ε2√
τpi
. (2.25)
Integrating (2.25), we obtain
R(τ) = 2ε2
√
τ
pi
+ C3, (2.26)
where C3 is given by the initial condition R(0) = 1. We can notice from (2.25) that Rτ is
infinite at τ = 0, which is an inevitable consequence of the discontinuity in concentration
at t = 0. However, this occurs over an infinitely small time, finally resulting in a finite R,
as shown by equation (2.26). In the original coordinates, we can write the solution for the
concentration and for the moving boundary
c(r, t) = erf
(
r −R
2
√
ε
t
)
− 1, R(t) = 2
√
εt
pi
+ 1. (2.27)
2.3. Small time analysis 15
2.3.2 Laplace transform
Another way to obtain an analytical solution is to apply the Laplace transform to the
governing equations in order to obtain a much simpler problem. Hence, we define the
Laplace transform of the function c(r, t) as
L{c(r, t)} =
∫ ∞
0
e−stc(r, t)dt = c˜(r, s). (2.28)
It has to be noticed in (2.28) that the variable r has to be independent. When we consider
r = R(t), the integral is affected. To overcome this problem, we make the assumption that
R(t) varies slowly with t, i.e. for ε → 0. This is also confirmed if we look at the Stefan
condition for small times. In fact, considering the variable change t = ετ and noting that
equation (2.3) becomes
dR
dτ
= ε
∂c
∂r
∣∣∣
r=R(τ)
, (2.29)
it is reasonable to assume that R(τ) is almost constant as ε → 0 and that the Laplace
transform has sense at the border. Applying (2.28) to (2.8), we obtain
L{∂τ c} = L
{
1
r2
∂r
(
r2∂rc
)}
, (2.30)
where
L{∂τ c} =
∫ ∞
0
e−sτ cτ (r, τ)dt =
∫ ∞
0
s e−sτ c(r, τ)dτ + e−sτ c(r, τ)
∣∣∣∞
0
= s c˜(r, s)− c(r, 0) = s c˜(r, s),
(2.31)
and
L
{
1
r2
∂r
(
r2∂rc
)}
= L
{
∂rrc+
2
r
∂rc
}
=
∫ ∞
0
e−sτ
[
∂rrc+
2
r
∂rc
]
dτ =
= ∂rr c˜+
2
r
∂r c˜ =
1
r2
∂r
[
r2∂r c˜(r, s)
]
,
(2.32)
that gives the equation
∂rr c˜(r, s) +
2
r
∂r c˜(r, s)− s c˜(r, s) = 0. (2.33)
The transformed boundary conditions associated to (2.9) are
c˜(R, s) = −1
s
, (2.34)
c˜(r →∞, s) = 0, (2.35)
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for s > 0 and neglecting the t variation in R in (2.34). The solution of the transformed
equation (2.33) will be
c˜(r, s) =
Ae
√
sr +Be−
√
sr
r
, (2.36)
where the constants A and B have to be found applying the boundary conditions. It is easy
to see that condition (2.35) implies A = 0 and condition (2.34) implies
Be−
√
sR
R
= −1
s
, (2.37)
giving the final solution
c˜(r, s) = −R
r
(
e
√
s(R−r)
s
)
. (2.38)
Applying the inverse Laplace transform to (2.38) we obtain
L−1{c˜(r, s)} = −R
r
erfc
(
r −R
2
√
τ
)
, (2.39)
that gives, coming back to the original time scale,
c(r, t) =
R(t)
r
[
erf
(
r −R(t)
2
√
ε
t
)
− 1
]
, (2.40)
which is exactly the same solution given by similarity variables for small times in equation
(2.27) for r ∼ R(t). In order to find an analytical expression for the moving boundary, we
can use this solution for the concentration in equation (2.39) and obtain
Rτ = ε cr|r=R(τ) = ε
(
1√
piτ
+
1
R(τ)
)
. (2.41)
Considering R = 1 + εR1 and the expansion of 1R , we can write (2.41) as
εR1τ = ε
[
1√
piτ
+ 1− εR1
]
, (2.42)
and considering just the leading order we can approximate
R1τ =
1√
piτ
+ 1. (2.43)
Integrating with respect to τ and coming back to the initial change of variables, we obtain
R1 = 2
√
τ
pi
+ τ = 2
√
εt
pi
+ εt, (2.44)
and finally we can write the analytical solution of the moving boundary for small times as
R(t) = 1 + 2
√
εt
pi
+ εt. (2.45)
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2.4 Exact and approximate solutions for large times
The aim of this section is to find an exact solution for large times via similarity methods
and compare that with approximate solutions obtained through perturbation analysis, the
heat balance integral method and numerical techniques.
2.4.1 Similarity solutions
Applying the same method of similarity variables detailed in Section 2.3.1, let c(r, t) = f(η)
where η = Artα, we can write equation (2.8) as
εfηαArt
α−1 = A2t2α
(
fηη +
2
η
fη
)
, (2.46)
that, for definition of η and multiplying for t both terms, implies
εfηαη = A
2t2α+1
(
fηη +
2
η
fη
)
. (2.47)
Again, in order to remove the time dependence, we set α = −1/2 and A = 1/2, and we
obtain
−εfη η
2
=
1
4
(
fηη +
2
η
fη
)
, (2.48)
that gives
−2fη
(
εη +
1
η
)
= fηη, (2.49)
where now η = Artα = r/(2
√
t). At this point, let define y = fη in order to obtain a first
order ODE:
yη = −2
(
εη +
1
η
)
y =⇒
∫
dy
y
= −2
∫ (
εη +
1
η
)
dη, (2.50)
that gives
log(y) = −εη2 − 2 log(η) + C1 =⇒ log(y) = log
(
e−εη
2
η−2
)
+ C1, (2.51)
and finally
y = C1e
−εη2η−2. (2.52)
Considering the definition of y, we integrate equation (2.52)∫
fη = C2
∫ (
e−εη
2
η−2
)
dη, (2.53)
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that gives
f(η) = −A1
(
√
εpi erf
(√
εη
)
+
e−εη2
η
)
+A2, (2.54)
and we now adjust the boundary conditions in order to find the constants of integration. To
allow A1 and A2 to be constant, we require R(t) ∝
√
t, and looking at the border condition
in η = R/(2
√
t) we choose
R(t) = 2λ
√
t, (2.55)
where λ is an unknown constant that has to be found. Conditions (2.9) lead to
f(η)|η→∞ = 0 =⇒ −A1
√
εpi +A2 = 0,
f(η)|η=λ = −1 =⇒ −A1
[
√
εpi erf
(√
ελ
)
+
e−ελ2
λ
]
+A2 = −1.
(2.56)
that gives
A1 =
λ
e−ελ2 − λ√εpi erfc (√ελ) ,
A2 =
λ
√
εpi
e−ελ2 − λ√εpi erfc (√ελ) .
(2.57)
Thus, we can define
A(λ) =
λ
e−ελ2 − λ√εpi erfc (√ελ) , (2.58)
that allows us to write the solution in the form
c(r, t) = A(λ)
[√
εpi erfc
(
r
2
√
ε
t
)
− 2
√
t
r
e−
εr2
4t
]
. (2.59)
From equation (2.55) we know that
dR
dt
=
λ√
t
, (2.60)
and substituting (2.60) into the Stefan condition (2.10) we have
∂c
∂r
∣∣∣
r=R(t)
=
λ√
t
. (2.61)
According to our variables change, we have cr = fηηr that gives
∂c
∂r
∣∣∣
r=R(t)
=
[
fη
1
2
√
t
]
η=λ
=
λ
e−ελ2 − λ√εpi erfc (√ελ)
[
e−εη2
η2
]
η=λ
1
2
√
t
=
e−ελ2
[e−ελ2 − λ√εpi erfc (√ελ)][2λ√t] .
(2.62)
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Therefore, we can write the equality between (2.60) and (2.62) and obtain
e−ελ2
[e−ελ2 − λ√εpi erfc (√ελ)][2λ√t] =
λ√
t
, (2.63)
that gives
2λ2 − e
−ελ2
e−ελ2 − λ√εpi erfc (√ελ) = 0. (2.64)
Finally, we obtain an equation for λ
2λ2
[
e−ελ
2 − λ√εpi erfc (√ελ)]− e−ελ2 = 0, (2.65)
and its solution, depending on ε, allows us to obtain the profile of R(t). It has to be notice
that this solution do not verify the initial condition R(0) = 1 and it is only valid for large
times, away from the initial condition.
2.4.2 Perturbation theory
We follow the perturbation method to find an approximate solution, by starting from the
exact solution of a related simpler problem. Thus, we want to approximate the concentration
and the moving boundary with a function of the form
c = c0 + εc1 + ε
2c2 + . . . and R = R0 + εR1 + ε2R2 + . . . (2.66)
and divide the original problem in simpler related problems. Substituting (2.66) into (2.8)
and grouping terms with the same power of ε, we obtain:
O(ε0) −→ 1
r2
∂
∂r
(
r2
∂c0
∂r
)
= 0 (2.67)
O(ε1) −→ 1
r2
∂
∂r
(
r2
∂c1
∂r
)
=
∂c0
∂t
(2.68)
O(ε2) −→ 1
r2
∂
∂r
(
r2
∂c2
∂r
)
=
∂c1
∂t
(2.69)
O(ε3) −→ . . . (2.70)
The related non zero boundary condition then becomes
c(R, t) = c0(R0 + εR1 + . . . , t) + εc1(R0 + εR1 + . . . , t) + . . . (2.71)
= c0(R0, t) + εR1
∂c0
∂r
∣∣∣
r=R0
+ εc1(R0, t) + · · · = −1. (2.72)
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which gives
c0(R, t) = −1, c0(∞, t) = 0, ci(R, t) = ci(∞, t) = 0 for i = 1, 2, . . .
R0(0) = 1, Ri(0) = 0 for i = 1, 2, . . .
(2.73)
From the first order (2.67) and boundary conditions (2.73), we can write
c0(r, t) = −R0(t)
r
. (2.74)
Therefore, using equation (2.74), the lower order of the Stefan condition will be
dR0
dt
=
∂c0
∂r
∣∣∣
r=R0
=
1
R0
, (2.75)
which gives the solution for the moving boundary profile
R0(t) =
√
2t+ 1, (2.76)
where the initial condition R0(0) = 1 has been applied. In order to solve the equation for
O(ε), we can use the solution (2.74) and the Stefan condition in order to write
∂c0
∂t
= −1
r
dR0
dt
= −1
r
(
∂c0
∂r
∣∣∣
r=R0
)
= − 1
rR0
. (2.77)
Substituting (2.77) into (2.68) and integrating twice, we obtain
c1(r, t) =
1
2
(
1− r
R0
)
+A
(
1
R0
− 1
r
)
, (2.78)
where the left boundary condition in (2.73) has been used and A is a constant that has
to be found applying the right boundary condition. However, we can observe that (2.78)
explodes as r →∞ suggesting that we can only use this solution at r ∼ R, and we should
rescale variables for large values of r.
2.4.3 Heat Balance Integral Method
For an alternative theoretical study of the function, we apply the heat balance integral
method, which was initially proposed by Goodman in the late 1950s in order to solve
thermal problems [44]. The HBIM is used to find approximate solutions to heat equation
and Stefan problems, where very few analytical solution can be found. Essentially, it follows
three steps:
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1. The introduction of a parameter δ that represents the diffusion depth: for r ≥ δ the
concentration change is negligible and hence c(δ, t) = 0 and cr(δ, t) = 0.
2. The definition of an approximate function dependent on δ and appropriate boundary
conditions.
3. The integration of the governing equation to produce the heat balance integral that
gives an ordinary differential equation for δ.
In order to simplify the diffusion equation (2.8), we also consider the change of variable
c = u/r and obtain the related system:
ε
∂u
∂t
=
∂2u
∂r2
, u(r, 0) = 0, R(t) < r < δ, t > 0, (2.79)
u(R(t), t) = −R(t), u(δ, t) = 0, t > 0, (2.80)
R(t)
dR
dt
=
∂u
∂r
∣∣∣
r=R(t)
+ 1, R(0) = 1, t > 0. (2.81)
As suggested in [73], we assume that the approximate function u is a polynomial of the
form
u(r, t) = a0 + a1
(
δ − r
δ −R(t)
)
+ a2
(
δ − r
δ −R(t)
)n
, (2.82)
where the coefficients a0, a1 and a2 may depend on time and δ is the diffusion thickness.
Using the boundary condition (2.80) at r = δ, we have:
u(δ, t) = 0 =⇒ a0 = 0,
∂u
∂r
∣∣∣
r=δ
= 0 =⇒ a1 = 0.
(2.83)
Moreover, evaluating (2.82) at r = R, we have
u(R(t), t) = a2 = −R(t), (2.84)
that gives the final approximating function:
u(r, t) = −R(t)
(
δ − r
δ −R(t)
)n
. (2.85)
In order to find the behaviour of δ and R, we consider the heat balance integral∫ δ
R(t)
ε
∂u
∂t
dr =
∫ δ
R(t)
∂2u
∂r2
dr, (2.86)
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that gives ∫ δ
R(t)
ε
∂u
∂t
dr =
[
∂u
∂r
∣∣∣
r=δ
− ∂u
∂r
∣∣∣
r=R(t)
]
. (2.87)
Putting (2.85) into the right side of (2.87), we have that ∂u∂r
∣∣
r=δ
= 0 and
∂u
∂r
∣∣∣
r=R(t)
=
nR(t)(δ − r)n−1
(δ −R(t))n
∣∣∣
r=R(t)
=
nR(t)
δ −R(t) . (2.88)
Moreover, for Leibniz’s theorem, we have
d
dt
∫ δ
R(t)
ε u(r, t)dr = ε
[
dδ
dt
u(δ, t)− dR
dt
u(R(t), t) +
∫ δ
R(t)
∂u
∂t
dr
]
= ε
{
dR
dt
R(t) +
∫ δ
R(t)
∂u
∂t
dr
}
,
(2.89)
where (2.80) is being applied. Therefore, (2.89) gives∫ δ
R(t)
ε
∂u
∂t
dr =
d
dt
∫ δ
R(t)
ε u(r, t)dr − εdR
dt
R(t). (2.90)
We can write the second integral as∫ δ
R(t)
ε u(r, t) dr = ε
∫ δ
R(t)
[
−R(t)
(
δ − r
δ −R(t)
)n]
dr = − εR(t)
(δ −R(t))n
[
−(δ − r)
n+1
n+ 1
]δ
R(t)
= −εR(t)(δ −R(t))
n+ 1
,
(2.91)
and obtain the equation
d
dt
[
εR(t)(δ −R(t))
n+ 1
]
+ ε
dR
dt
R(t) =
nR(t)
δ −R(t) . (2.92)
Using the Stefan condition (2.81) we finally obtain the ODEs system
dR
dt
=
n
δ −R(t) +
1
R(t)
, (2.93)
dδ
dt
=
[
ε(n− 1)2 − n2 − n]R2(t) + 2εδ(n− 1)R(t) + εδ2
R2(t)(R(t)− δ)ε , (2.94)
with the initial conditions R(0) = δ(0) = 1. In fact, at the beginning, diffusion does not
occur and consequently the thickness initial condition correspond to the initial value of the
radius. In order to avoid the singularity at the initial point, we proceed with a small time
analysis and suppose that
R(t) = 1 + 2ν
√
t. (2.95)
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Putting this expression into the Stefan condition (2.93) we obtain
(
1 + 2ν
√
t
) d
dt
(
1 + 2ν
√
t
)
=
n
(
1 + 2ν
√
t
)
δ −R(t) + 1, (2.96)
that gives (
1 + 2ν
√
t
) ν√
t
=
n
(
1 + 2ν
√
t
)
δ − (1 + 2ν√t) + 1. (2.97)
Thus, the term (δ −R) has to balance the factor √t, e.g. we suppose that
δ = 1 + 2µ
√
t, (2.98)
obtaining
ν =
n
2(µ− ν) , (2.99)
that gives
µ = ν +
n
2ν
. (2.100)
Putting (2.95) and (2.98) into the HBIM equation, we obtain
ε
[
d
dt
(
(1 + 2ν
√
t)(2(µ− ν)√t)
n+ 1
)
+
ν√
t
(1 + 2ν
√
t)
]
=
n(1 + 2ν
√
t)
2(µ− ν)√t , (2.101)
and due to the fact that t 1, we can approximate this expression as
ε
[
d
dt
(
2(µ− ν)√t
n+ 1
)
+
ν√
t
]
=
n
2(µ− ν)√t , (2.102)
that leads to
ε
[
n
2ν(n+ 1)
+ ν
]
= ν, (2.103)
where (2.100) has been used to substitute µ. We can finally write an expression for ν as
ν =
√
εn
2(1− ε)(n+ 1) , (2.104)
that gives
R = 1 +
√
ε n t
2(1− ε)(n+ 1) . (2.105)
Putting (2.104) into (2.100) we have
µ =
n [(1− ε)n− 1]√
2(1− ε)(n+ 1)εn, (2.106)
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hence
δ = 1 +
n [(1− ε)n− 1]√t√
2(1− ε)(n+ 1)εn. (2.107)
Thanks to this analysis we can choose an initial value for R and δ at t0  1 and calculate
the approximate solution of (2.93)–(2.94) using the MATLAB in–built function ode45. The
issue is understand which is the best choice for n in the approximate function. Langford
[60] proposed a definition of an error for the HBIM method through the integral of the
energy. Myers [78] used this definition to minimize the error leaving the exponent unknown.
Applying this strategy to our problem we obtain that the error
En(t) =
∫ δ
R
[
ε
∂u
∂t
− ∂
2u
∂r2
]2
dr (2.108)
is minimized for n = 3.7.
2.4.4 Numerical approximation
As we have to deal with a numerical approximation, we introduce a constant δf that
represents the diffusion depth as in Section 2.4.3. We transform the system (2.79)–(2.81)
fixing the boundary through the change of variables
η =
r −R
δf −R, τ = t, (2.109)
obtaining the equivalent system
ε
∂u
∂τ
= ε
dR
dτ
(
1− η
R− δf
)
∂u
∂η
+
1
(R− δf )2
∂2u
∂η2
, 0 < η < 1, (2.110)
u(0, τ) = −R, u(1, τ) = 0, u(η, 0) = 0, (2.111)
R
dR
dτ
=
1
(R− δf )
∂u
∂η
∣∣∣
η=0
+ 1, R(0) = 1. (2.112)
Let define the discrete variables in space and time
ηj = j∆η for j = 0, . . . , J,
tn = n∆τ for n = 0, . . . , N.
(2.113)
Thus, considering the notation unj = u(ηj , t
n), we approximate the diffusion equation
(2.110) using first order Euler for the time derivative and central difference for the spatial
derivatives, as:
∂u
∂τ
≈ u
n+1
j − unj
∆τ
,
∂u
∂η
≈ u
n
j+1 − unj−1
2∆η
,
∂u
∂η
≈ u
n
j+1 − 2unj + unj−1
∆η2
. (2.114)
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The behaviour of the boundary is given by forward difference in time and the three-term
backward difference of the solution, i.e.
dR
dτ
≈ R
n+1 −Rn
∆τ
,
∂u
∂η
∣∣∣
η=0
≈ 3u
n
1 − 4un2 + un3
2∆η
. (2.115)
Hence, equation (2.110) can be approximated as
ε
(
un+1j − unj
∆τ
)
=ε
(
Rn+1 −Rn
∆τ
)(
1− ηj
Rn − δf
)(
unj+1 − unj−1
2∆η
)
+
1
(Rn − δf )2
(
unj+1 − 2unj + unj−1
∆η2
)
,
(2.116)
where
Rn+1 =
∆τ
Rn(Rn − δf )
(
3un+11 − 4un+12 + un+13
2∆η
)
+
∆τ
Rn
+Rn, (2.117)
subject to R1 = 1. Multiplying (2.116) by (Rn − δf )2∆τ , defining ν = ∆τ/2∆η and
µ = ∆τ/∆η2, we can write the scheme as
an+1un+1j−1 + b
n+1un+1j + d
n+1un+1j+1 = e
nunj , (2.118)
where
an+1 = ε(Rn − δf )(1− ηj)ν Rn+1τ − µ,
bn+1 = ε(Rn − δf )2 + 2µ,
dn+1 = −ε(Rn − δf )(1− ηj)ν Rn+1τ − µ,
en = ε(Rn − δf )2.
(2.119)
Boundary and initial conditions can be written as
un+10 = −Rn, un+1J = 0, u1i = δηi + 1. (2.120)
We can write the system in the matrix form
MnUn+1 = Un, (2.121)
for n = 1, . . . , T − 1, which expanded becomes
an+11 b
n+1
1 d
n+1
1 0 . . . . . . 0
an+1 bn+1 dn+1 0 . . . . . . 0
0 an+1 bn+1 dn+1 0 . . . 0
0 0
. . . . . . . . . . . . 0
0 . . . . . . . . . an+1 bn+1 dn+1
0 . . . . . . . . . . . . 0 1


un+11
un+12
...
...
un+1J−1
un+1J

=

en+11
enun2
...
...
enunJ−1
en+1J

. (2.122)
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At each time we solve the system (2.121) and we use the solution Un+1 to solve the Stefan
condition (2.117).
2.5 Results
The approximations described in this chapter are compared in Figure 2.2 for ε = 0.01.
In Figure 2.2(a) we can observe the behaviour of the solutions for the concentration at
a fixed time t¯. The image shows good agreement between the similarity solution (2.59)
where λ = 0.75, the numerical approximation given by solving (2.121) and the HBIM
method obtained from re-scaling (2.85) with n = 3.7. In particular, the latter two are
almost undistinguishable. On the other hand, in Figure 2.2(b) the profile for the radius
shows the limits of some methods. While there is an excellent agreement between the
numerical solution given by (2.117) and the HBIM approximation (2.93), it is clearly shown
the invalidity of the similarity solution described in (2.55) for small times.
(a) (b)
Figure 2.2: Comparison of (a) the concentration and (b) the particle radius profiles given by the
similarity variables method (dashed line), the HBIM (dots) and the numerical approximation (solid
line) with ε = 0.01.
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Abstract
We examine the standard model for diffusion and surface kinetics driven growth of a single
spherical particle in solution and show that it is applied incorrectly throughout the
literature. It is shown that crystal growth occurs in two distinct stages: an early time
where the growth rate is large and a late time, when the rate decreases. The definition of
’early’ depends on the particular experiment, but may be of the order of hundreds of
seconds. It is only during the late time that the standard model holds. Authors typically
fit the model to all experimentally obtained growth data however since it is invalid in the
early time stage this leads to incorrect values for the diffusion and surface kinetic
coefficients. In fact the model cannot even distinguish between diffusion or surface kinetics
driven growth, although the majority of authors assume one or the other to be the
dominant driving force: since the model cannot distinguish either assumption leads to
equally good results. Applying the model correctly shows that the growth is controlled by
a single non-dimensional group: practically this means that the growth data may only be
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used to predict a single unknown. Previous studies, where 2, 3 or 4 parameters were
calculated have redundancy. The Gibbs-Thomson relation plays an important role but, in
the cases studied here it has a noticeable effect only during the first growth stage where
the model does not hold. On a more positive note, we finish by providing an explicit
relation for the variation of the radius with time. This is the first such relation in the
literature and, for large times with just a single fitting parameter, excellent agreement
with experimental data on CdSe nanocrystal growth is demonstrated.
3.1 Introduction
Nanocrystals or chemically grown quantum dots have a wealth of uses, such as in solar cells,
light emitting diodes, biological markers, optoelectronic devices and nanoelectronics [24, 71,
102]. It is estimated that semiconductor quantum dots may have a market value of over $4
billion by 2020 [15]. Since nanocrystal properties are tunable by adjusting their size and/or
shape it is essential to be able to prepare monodisperse particles in a reproducible manner.
To do this requires a clear understanding of the growth process, yet surprisingly there
is a lack of theoretical understanding for the process of growing nanocrystals in colloidal
solutions [104] and consequently production is still primarily carried out via small batch
processes and trial and error [15].
In this paper we study the standard model for colloidal spherically symmetric crystal
growth. Obviously this has application in a multitude of synthetic growth processes, however
we will focus primarily on the nanoscale due to the current high interest in this field. LSW
theory [7] is currently the most popular theoretical method to describe the colloidal crystal
growth process. The initial stage of this theory is to apply a kinetic model, whereby the
growth rate of each crystal depends on the local solute concentration, diffusion rate and
surface kinetics. Mathematically this leads to a diffusion equation in the solute, coupled to
a mass balance which describes the growth rate of the crystal. The growth rate obtained
through this analysis is then introduced into a continuity equation to calculate the particle
size distribution. With multiple particles it is possible to predict Ostwald ripening or
size focussing and to identify the key parameters controlling the process. It is therefore
essential to understand and to correctly apply the basic building block, the kinetic model,
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and for this reason it is discussed in detail by many authors. Sugimoto [103] uses the
kinetic model to provide a detailed theoretical and practical discussion of crystal growth.
Peng et al. [89] focus solely on the context of nanocrystal growth. In several nanocrystal
studies [7, 17, 23, 24, 71, 102, 104] the kinetic model is typically solved, subject to various
assumptions, to obtain an expression for t(r) (the change of time with radius, since the
function cannot be inverted to r(t)) and then the diffusion and surface kinetic coefficients
obtained via comparison with experimental data. All are able to obtain good agreement
to the data despite the fact different driving mechanisms (diffusion/surface kinetics) are
assumed to dominate and distinct growth regimes are observed. This means that different
numbers of fitting parameters are used in the various studies.
3.2 Growth of a single particle
We now focus on the typical scenario involving a single, spherical nanoparticle, with
radius rp. We assume the standard La Mer model [58] which is based on temporal
separation between nucleation and growth and then model only the period of particle
growth. The system is dilute, such that particle interaction and aggregation are neglected.
The growth is always spherically symmetric, i.e. we average the typical atom by atom
growth: this assumption becomes more reasonable as the size increases. The affect of any
solvent used to facilitate the growth process is accounted for by the diffusion and or
kinetic rate constant. The monomer concentration at the particle surface and in the
far-field are Ci and Cb, respectively. The particle solubility, Cs is given by the
Gibbs-Thomson (or Ostwald-Freundlich) relation
Cs = C∞ exp
{(
α
rp
)}
, (3.1)
where α is the capillary length and C∞ is the bulk solubility of the particle, i.e. when
rp →∞. If Cs < Cb then monomer molecules diffuse from the bulk towards the particle to
react with the surface and the particle grows, whereas if Cs > Cb the particle shrinks.
The monomer concentration, C, is described by the diffusion equation
∂C
∂t
=
D
r2
∂
∂r
(
r2
∂C
∂r
)
, (3.2)
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where r is distance from the centre of the particle and t is time. This is subject to
C(rp, t) = Ci(t) , C(rp + ,.t) = Cb(t) , C(r, 0) = C0 for r > rp , (3.3)
where the last condition states that initially the monomer solution is well-mixed and at a
uniform concentration, C0. To conform with standard literature (see Refs. [69, 103, 108]),
we have included a diffusion layer of width δ around the particle, where the concentration
adjusts from Ci to Cb.
In practice the concentration adjacent to the particle surface, Ci, is difficult to measure.
It may be eliminated from the model by considering two equivalent expressions for the mass
flux at the particle surface, J . Fick’s first law relates the flux of monomers passing through
a spherical surface of radius r to the concentration gradient
J = 4pir2D
∂C
∂r
=
4piDrp(rp + δ)
δ
(Cb − Ci) , (3.4)
where D is the constant diffusion coefficient. Invoking a first-order surface reaction, the
flux is also proportional to the difference between monomer concentration adjacent to the
particle and the particle surface concentration
J = 4pir2pk(Ci − Cs) , (3.5)
where k is a rate constant. Equating (3.4) with (3.5) gives
Ci = Cs +
D
k
∂C
∂r
∣∣∣∣
r=rp
, (3.6)
which defines the concentration Ci for the surface condition of (3.3).
The diffusion equation must be solved on a domain r > rp, where the particle radius is
an unknown function of time. To determine the radius we impose the mass balance
d
dt
(
4
3
pir3p
)
= 4pir2p
drp
dt
= VmJ , (3.7)
which upon substituting for J (at r = rp) yields
drp
dt
= VMD
∂C
∂r
∣∣∣∣
r=rp
, rp(0) = rp0 , (3.8)
where rp0 > 0 is the initial particle radius.
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To complete the system we require an expression for the time-dependent bulk
concentration, Cb(t). The volume of solute per particle is 1/N0, where N0 is the
population density. A mass balance within the volume surrounding a particle gives
1
N0
MpC0 = MpCb(t)
(
1
N0
− 4pi
3
r3p
)
+
4pi
3
ρpr
3
p , (3.9)
where Mp is molar mass. On the left hand side is the total amount of monomer initially in
the solute, before nucleation has occurred. The first term on the right hand side represents
the amount of monomer at time t, but now the volume occupied by monomer is the original
value minus the space taken up by the nanocrystal. Finally, monomer has been used to
create a nanocrystal with density ρp, which is the final term. LSW theory is valid for dilute
systems, where particle-particle interaction is negligible, which means that 4pir3pN0/3  1
(this is easily verified using the values of Table 3.1). Noting that VM = Mp/ρp we obtain
Cb(t) ≈ C0 − 4pi
3
ρp
Mp
N0r
3
p = C0 −
4pi
3
N0
VM
r3p . (3.10)
The system is now fully defined: monomer concentration is described by equation (3.2),
subject to the boundary conditions (3.3) and holds for r > rp(t) where rp satisfies (3.8),
the bulk concentration required for the boundary conditions is given by (3.10).
Mathematically the problem is analogous to the melting or solidification of a spherical
nanoparticle, as described in Refs. [36, 93], where the melt temperature is a function of
the radius (following the Gibbs-Thomson relation). It is well-known from this theory that
even for simple configurations there is no analytical solution and so approximate or
numerical solutions are required.
3.2.1 Pseudo-steady state solution
The pseudo-steady state approximation is simply obtained by neglecting the time derivative
in (3.2) and integrating the resultant ordinary differential equation:
C = Cb +
kr2p
D(rp + δ) + kδrp
[Cb − Cs]
(
1− rp + δ
r
)
. (3.11)
The ‘constants’ of integration (which may be time-dependent since the integration is with
respect to r) come from applying the boundary conditions in (3.3) and replacing Ci from
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(3.6). The concentration Cs(t) is defined by the Gibbs-Thomson equation (3.1) and Cb(t)
by equation (3.10). The growth rate of the particle comes from equation (3.8)
drp
dt
= VMD
k(rp + δ)
D(rp + δ) + kδrp
(Cb − Cs)
= D
k(rp + δ)
D(rp + δ) + kδrp
[
VM (C0 − C∞eα/rp)− b3r3p
]
, (3.12)
where b3 = 4piN0/3.
Equation (3.11) describes the evolution of the concentration over time, it contains the
unknown δ, which represents the width of the adjustment zone where the concentration
increases from the particle edge to the bulk value. This is more commonly termed the
boundary layer. Diffusion boundary layers are time-dependent and, if the fluid is initially
well-mixed, δ(0) = 0 < rp. In the pseudo-steady approximation there is no way to calculate
δ(t). It may only be obtained via a full time dependent calculation (numerical) or certain
approximation techniques, see Ref. [78]. The growth equation (3.12) also contains δ(t),
consequently in its present form the pseudo-steady solution is of no practical use.
3.3 Standard solution method
To permit a tractable mathematical model a number of assumptions are made in the
literature, these include: pseudo-steady state diffusion; a diffusion layer thickness which is
significantly greater than the particle size; neglect of the Gibbs-Thomson relation
(resulting in a constant particle solubility) [7, 110]. The first two assumptions are so
widely accepted that they are usually stated regardless of the experimental procedure,
then analysis proceeds without discussion of their validity. We will investigate when these
assumptions are reasonable in a later section.
Following the pseudo-steady assumption, setting δ  rp and taking Ceq = C∞eα/rp to
be constant leads to
C = Cb +
kr2p
(D + krp)δ
[Cb − Ceq]
(
1− δ
r
)
(3.13)
drp
dt
=
Dk
D + krp
[
a3 − b3r3p
]
, (3.14)
where a3 = VM (C0 − Ceq). Integration of equation (3.14) leads to an implicit equation for
t(r)
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t− t0 = 1
6a2b2Dk
[
(bD + ak)
{
ln
a2 + abrp + b
2r2p
(a− brp)2 − ln
a2 + abrp0 + b
2r2p0
(a− brp0)2
}
+2
√
3(bD − ak)
{
arctan
(
a+ 2brp√
3a
)
− arctan
(
a+ 2brp0√
3a
)}]
.
(3.15)
The governing equations of this section and the solution (3.15) are quoted in numerous
papers on nanocrystal growth, see Refs. [17, 23, 71, 102] for example, but here we have
explicitly written down the contribution of the initial condition, such that t(rp0) = t0. We
refrain from specifying t0 = 0 since a number of authors report the growth occurring in two
distinct stages, then t0 could represent the start time of the second stage and rp(t0) = rp0
the corresponding particle radius. As is frequently stated this equation cannot be inverted
in order to express r(t).
A list of typical values used in the standard model or obtained by fitting to experimental
data is provided in Table 3.1. Numbers in bold have been estimated from figures in the
respective papers or calculated. If we take the example of Chuang et al. [23], they have
graphs for Cd in µmol/g, we convert this to mol/m3 by multiplying by the solution density
0.9g/cm3. Their graph, Fig. 4, shows a maximum C0 ≈ 10.5µmol/g = 9.45 mol/m3. The
final concentration, when growth has stopped, is Ceq ≈ 0.08 mol/m3. From this we calculate
a3 = VM (C0−Ceq) ≈ 3.1× 10−4. Their experimental maximum radius rm = 2.89nm where
rm = a/b, hence b3 = 1.28 × 1022. To determine C∞ requires the value of the capillary
length α = 2σVM/(RGT ), which is calculated using the values quoted in [89]: σ = 0.44J/m2,
RG = 8.31 J/mol/K, VM = 3.3× 10−5 m3/mol and the temperatures provided in the table
then C∞ = Ceqe−α/rm . The values of N0 (init.) are the numbers quoted in the paper,
usually estimated from a concentration curve, the value N0 (fin.) is calculated from the
value of b3 = 4piN0/3 obtained by fitting to experimental data. For Ref. [102] we only
present data for their "curve 2". The choice of region is discussed later.
3.4 Diffusion and kinetics driven cases
Various authors have assumed that the process is driven solely by diffusion or surface
kinetics, which leads to a slightly simpler solution form. In either case during the
derivation of equation (3.14) the number of expressions for the flux is reduced which then
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Param./Units Su [102] Chuang [23] Pan [85] Bullen [17]
N0 (init.) [No. m−3] 3.92× 1022 4.8× 1021 - -
N0 (fin.) [No. m−3] 8.19× 1022 3.02× 1022 3.19× 1021 4.6× 1022
C0 [mol m−3] - 9.45 2.5 50
Ceq [mol m−3] - 8× 10−2 6.1× 10−4 3.29
C∞ [mol m−3] - 7.9× 10−3 8.95× 10−6 0.131
a3 [1] 6.59× 10−5 3.1× 10−4 8.25× 10−5 1.54× 10−3
b3 [m−3] 3.43× 1022 1.28× 1022 1.34× 1022 1.93× 1023
D [m2 s−1] 9.10× 10−18 1.5× 10−16 no D no D
k [m s−1] 7.97× 10−9 no k 9.74× 10−10 2.2× 10−8
T [K] 503 523 473 538
rm [nm] 1.24 2.89 1.75 2.015
α [nm] 6.95 6.68 7.39 6.5
Table 3.1: Comparison of the parameters for nanocrystal growth in different studies.
prevents the determination of the unknown concentration, Ci, required in the boundary
condition.
In the diffusion limited case there can be no flux due to surface reaction, this requires
either setting Ci = Ceq or k = 0. Setting k = 0 in (3.14) leads to zero growth, hence the
diffusion limit can only be theoretically achieved by adjusting the concentration. That is,
for purely diffusion driven growth the value of the concentration in the solute adjacent to the
particle must be exactly equal to the equilibrium concentration of the particle throughout
the process. In the surface reaction driven case the diffusion term tends to zero provided
Ci = Cb orD = 0. Again we may immediately rule outD = 0 and so in this case the value of
Ci must be exactly the bulk concentration throughout the process. Further, equation (3.4)
indicates that if Cb = Ci then ∂C/∂r = 0 and hence C = Cb everywhere: the surface kinetics
limit requires that the concentration is constant in space throughout the process. From this
point of view it seems clear that the reductions are physically unrealistic. However, if we
do apply them then the surface reaction driven solution of Refs. [17, 85, 102] is obtained
by setting ak = 0 in (3.15), the diffusion driven solution of Refs. [23, 71, 102] is obtained
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by setting bD = 0.
3.5 Validity of the assumptions
The particle growth and solute concentration equations form the basis of LSW theory [7].
To correctly describe nanocrystal growth and Ostwald ripening and so better control the
process it is essential that the governing equations are correctly derived and analysed. In
the following we will highlight a number of errors common to the literature and show how
they may be corrected and interpreted. Finally we illustrate the conclusions by comparison
with experimental data.
The pseudo-steady assumption relies on the fact that diffusion occurs over a much
faster time-scale than growth, hence the concentration has sufficient time to equilibrate
to its steady-state value as the growth slowly proceeds, that is, the diffusion time-scale is
much smaller than the growth time-scale tD  tG. From the diffusion equation we can
see how time scales with distance, tD ∼ r2/D. From equation (3.8) the growth time-scale
tG = r
2/(VMD∆C), and so tD/tG = VM∆C. Since VM∆C is of the order of a3 we see from
Table 3.1 that VM∆C ∼ a3  1 hence the standard pseudo-steady approximation will be
accurate.
Now consider the approximation δ  rp, inherent to all analyses, where δ(t) is the
thickness of the boundary layer and for a well-mixed solution δ(0) = 0. Immediately it is
clear that the approximation is invalid at small times. The question is then, what constitutes
small time? As discussed above for diffusion it is well-known that in spherical problems
time and distance scale as tD ∼ r2/D, which then indicates that the boundary layer grows
as δ ∼ √Dt. If we assume δ = 30rp is sufficiently large to satisfy δ  rp, taking D from
the first two columns of Table 3.1 and a typical value rp = 1nm then the time taken to
achieve δ  rp is t = (30rp)2/D which varies approximately between 10-100s. That is, we
can expect the approximation δ  rp to be accurate beyond times of the order 100s. In fact
this is clear from inspection of published experimental data. In [102, Fig 5] the first five
data points (up to around 200s) follow a distinct curve to those for larger t, thus forcing
the authors to find two sets of fitting parameters, for "curve 1" and "curve 2" (using the
D value of Table 3.1 gives t of order 100s). The evolution of the diameter shown in [23,
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Fig.3] also shows a distinct form for t < 50s (their D value gives t of order 10s). Mendez
et al. [71] discuss zones 1 and 2 for three different sets of results, the change occurs around
125s for two and 250s for the third. Without discussing specific zones, Brauser et al. [15,
Fig.2a] presents a ’short time’ solution, valid to around 100s. Bullen et al. [17] state that
at early times the ‘radius grows almost linearly’. Of course not all data shows such a clear
demarcation, but there appears to be sufficient evidence to verify our assertion of a two-
stage growth process, where the boundary layer increases in size until becoming significantly
larger than the particle. So, from now on we will refer to Stages 1 and 2 to denote early
and late time regimes respectively, and our analysis shows that when calculating system
parameters data from Stage 1 should be neglected.
The Gibbs-Thomson equation (3.1) specifies the variation of the particle solubility with
the radius. With the exception of [104] the variation is generally neglected based on the
assumption that α  rp [63, 103]. However, in Table 3.1 we have α ∈ [6.5, 7.39]nm, while
in the experiments rp(0) ≈ 1nm, this results in a typical factor of e7 ≈ 103 difference
between taking the exponential form at early times or simply setting Cs = C∞, indicating
the importance of the Gibbs-Thomson relation. To be clear, neglecting the exponential
variation will lead to huge errors in the model predictions. So, how is it possible that
previous researchers appear to have good agreement with data when making such a poor
approximation? To understand this consider the data of Chuang et al. [23] from Table 3.1:
C0 = 9.45mol/m3, Cs = 7.9 × 10−3e6.68/rp . If we take the initial radius rp = 1nm then
Cs(0) = 6.29 ≈ 0.7C0, however due to the exponential dependence Cs rapidly decreases as
rp increases to its maximum of 2.89nm: when rp = 2nm Cs = 0.22, which is now negligible.
As we will see in the comparison to experiment Stage 2 only starts when rp ≈ 2.5nm.
Consequently, although the Gibbs-Thomson relation plays a controlling role in particle
growth during the Stage 1 this is when the standard model is not applicable. In modelling
the growth of a single crystal, in Stage 2, the solubility plays a minor role and could be set
to Cs = C∞ with negligible effect on the results. However, despite its minor contribution
to growth of a single particle it does play an important role in the growth of a group of
nanocrystals. With a single crystal growth stops when the maximum radius is reached, with
a group of crystals one particle may have reached its limit while others are still growing,
this acts to reduce the bulk concentration and then Cb − C∞eα/rp can become negative,
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leading to the particle shrinking. In this way the growth or death of particles can depend
crucially on the value of eα/rp .
3.6 An explicit solution for r(t)
Bullen et al. [17] state that while the evolution equation (3.14) is simple its solution is not,
which makes the fitting of data a non-trivial task. Below we detail how the solution may
be inverted to provide a simple form for rp(t), with a negligible error.
Since we only work in Stage 2 of the growth process we may neglect the exponential
variation and define Ceq = C∞eα/rm as constant, then equation (3.15) which describes the
relation t(rp) contains two distinct terms, involving arctan and log. This combination of
terms prevents the inversion to rp(t). The ratio of these terms is
λ =
2
√
3(bD − ak)
(bD + ak)
 arctan
(
a+2brp√
3a
)
− arctan
(
a+2brp0√
3a
)
ln
(
a2+abrp+b2r2p
a−br2p
)
+ ln
(
a2+abrp0+b2r2p0
a−br2p0
)
 . (3.16)
Taking the parameter values of Su et al. [102] this has a maximum value of approximately
2.5× 10−3 which is achieved at t = 0, it then decreases monotonically to zero as rp → a/b,
when the log term has a singularity. This means that the arctan term is always negligible
compared to the log term and if it is dropped from the model the errors will be of the
order 0.1%. Removing this term we find that both diffusion and kinetic driven processes
are accurately approximated by a solution of the form
t− t0 = 1
6ab
ak + bD
akbD
[{
ln
a2 + abrp + b
2r2p
(a− brp)2 − ln
a2 + abrp0 + b
2r2p0
(a− brp0)2
}]
= G ln
f(rp)
f(rp0)
.
(3.17)
Equation (3.17) is easily inverted to determine the radius as a function of time
f(rp) = f(rp0) exp
(
t− t0
G
)
, (3.18)
where f(x) = (a2 + abx + b2x2)/(a − bx)2 = (r2m + rmx + x2)/(rm − x)2, where rm is the
radius when growth stops. This is a quadratic equation for rp with solution
rp =
rm
2
[
1 + 2 f (rp0 ) exp
(
t−t0
G
)−√−3 + 12 f (rp0 ) exp ( t−t0G )][−1 + f (rp0 ) exp ( t−t0G )] . (3.19)
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A feature made clear from the parameter G = (ak + bD)/(6ab(akbD)) is that ak and
bD are interchangeable: it does not matter if we define them the opposite way round,
the result is the same. Physically this means that the model cannot distinguish between
diffusion or reaction driven growth. Consequently in the literature authors have been able
to approximate experimental data, irrespective of the assumed driving mechanism. The
equivalence my be confirmed by examination of the data of Table 3.1: only Su et al. [102]
calculates both k and D to find ak ≈ 3.2 × 10−10, bD ≈ 3 × 10−10, which only differ by a
few percent. In fact, as we discuss later, the small difference is most likely related to their
solver or rounding errors.
The goal in developing a theoretical model is to determine how the controlling
parameters influence the process and so understand how to optimise the growth. Part of
this involves the determination of the diffusion and/or surface kinetic coefficients as well
as the parameters a, b by fitting the model to the experimental data. Previous researchers
have used the data to solve for all four, or just three in the diffusion or surface kinetic
driven limit. In fact Su et al. [102] solve for eight parameters, four in each of their two
stages. It is well-known that the more parameters there are to fit the less the chance of an
accurate or even correct solution. For non-linear equations such as we have here there may
be infinitely many solutions and the fitting algorithm may easily settle on an incorrect
one. The non-uniqueness can be seen from the results of Mendez et al [71], who calculate
a3 = 2.21 × 106, b3 = 2.7 × 1032, D = 9.99 × 10−28. The first two values are ten orders of
magnitude greater than the values quoted by Su et al. [102] and Chuang et al. [23], the
diffusion coefficient ten orders smaller yet they provide an excellent fit to their
experimental data (shown in their Fig. 5 G3.5 solution). However the time-scale to reach
the state where δ  rp is of the order 1011s ≈ 32, 000 years as opposed to the observed
125s. Their solver has settled on a theoretically possible but physically unrealistic
solution.
If we examine equation (3.19) we see that, provided rm is measured, there is in fact just
a single unknown, G, to solve for: this is a relatively simple task and with much less chance
of settling on an incorrect solution. If rm is not measured then there are two unknowns,
which again is significantly simpler and more reliable than fitting to three or four unknowns.
For the present study we take rm to be the maximum value obtained in the experiments, for
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certain cases this must be viewed as an approximation: with Chuang et al. [23] it is clear
that the growth process has stopped, whereas with Pan et al. [85] it appears the crystal
could slightly increase in size if the experiment were carried on for longer. We then apply
a simple least-squares fit to the data in the Stage 2. In certain cases this stage is easily
identified, for others it is not clear. However, if t0 is chosen to be too large it should not
make a difference to results, provided we are in Stage 2 the value obtained for G should
remain approximately constant, regardless of the number of experimental points. As an
example we note that in the results shown below the value obtained for G when using the
data of Chuang et al. [23] changed by 1% when starting at the 5th or 6th data points.
Given that we cannot use growth data alone to determine important parameters such
as the diffusion coefficient or surface reaction rate it is clear that we must employ other
experimental data to complete the system. In this case we propose using the measured
concentration data. If we take the example of Chuang et al. [23] we have so far
determined G = 28.28, using their measured rm = 2.89nm. Their initial concentration
C0 = 9.45mol/m3 and the process stops when Ceq = C∞eα/rm = 0.08mol/m3, the molar
volume is VM = 3.3 × 10−5m3/mol. This allows us to calculate
a3 = VM (C0 − Ceq) = 3.09 × 10−4 and hence b3 = (a/rm)3 = 1.28 × 1022. Since ak = bD
then rm = a/b = D/k and G = rm/(3a3k) = r2m/(3a3D) indicates k = 1.1 × 10−7,
D = 3.3× 10−16 (note, they obtain a value D = 1.5× 10−16).
In Figures 3.1 and 3.2 we compare the results of the present model with experimental
data from Refs. [17, 23, 85, 102]. The dots represent the experimental data, the solid line
the curve described by equation 3.19 with G provided by the least squares calculation,
the dashed line is obtained by using the parameter values quoted in the respective papers
in (3.19). Fig 3.1(a) shows the crystal growth reported by Chuang et al. [23]. The first
four points approximately follow a straight line, so we assume they occupy Stage 1 and
so take rp0, t0 as the position of the fifth data point. The maximum radius measured is
rm = 2.89nm, after substituting this into equation (3.19) and carrying out a least-squares
fit to the final six points we obtain G = 28.28. Note, in some experiments there is a clear
demarcation between zones but this is not always the case. However, provided we only
use data from Stage 2 the choice of starting point should be irrelevant. For example, if we
only use the final five points in the least squares calculation then we obtain G = 28.56,
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which is a 1% increase on the previous value. Taking the values from Table 3.1 we obtain
G = r2m/(3a
3D) ≈ 60, with leads to a rather poor fit. In fact their paper shows a better fit to
data, but unfortunately they do not state the values of a, b obtained, only the value of D and
the ratio a/b = 2.885 (which is slightly below the experimental value), so it is not possible
to reproduce their fitting curve. Our result suggests D = r2m/(3a3G) ≈ 3.18× 10−16 which
is more than double their quoted value. The fact they obtain a good fit with a different
value for D is indicative of the non-uniqueness of solutions and the difficulties of fitting to a
number of parameters. For the data of Bullen et al. [17] we take rp0, t0 from the 4th point,
although from the figure it appears that the 3rd would be an equally good starting point.
This leads to G = 18.82. The data of Table 3.1 indicates a value G = rm/(3a3k) ≈ 19.66
which also leads to good agreement between the data and equation (3.19).
Figures 3.2(a) and 3.2(b) show the comparisons between the data of Refs. [85, 102].
In these two cases the growth is much slower than the previous examples and G increases
accordingly. For Pan et al. [85] we take Stage 2 as starting at the 5th point (n = 5, the
first four points follow a clear straight line) to obtain G = 1166, the data quoted in Table
3.1 gives G = 7602 which leads to very poor agreement with the data. Note Pan et al. [85]
calculate a, b from their concentration data and only use the growth data to determine k.
Using their value for a3 = 8.25 × 10−5 and taking the final radius rp = 1.75nm as being
approximately the maximum radius and G = 1166, we obtain k = 6.06× 10−9 as opposed
to their quoted value of 9.74× 10−10. This new value is consistent with that quoted by Su
et al. [102]. For the final figure we start at the 9th point, since the first eight points appear
to follow a different trend. This leads to G = 789.3 which is very close to the value of Table
3.1, G = 824. Both G values provide an excellent approximation, although our prediction
obviously leads to a lower least squares error.
We have presented results for the growth of Cd crystals although it is clearly applicable
to other materials. Varghese et al. [107] study the growth of platinum. In their Figure 7
they show the evolution of the average diameter over time. They claim the data cannot be
fitted using the diffusion model alone, so they add an extra term (and so an extra fitting
parameter) to account for surface reaction and consequently find a good fit to the data.
However, if we set rm = 2.4nm (although their growth has clearly not finished) we find
an equally good fit to their final five data points, t > 18 minutes, with the one-parameter
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Figure 3.1: Chuang et al. [23] G = 28.28, rm = 2.892, n = 5 (n = 6, G = 28.56 = 1% change),
Bullen et al. [17] G = 18.82, n = 4, rm = 2.015.
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Figure 3.2: Pan et al. [85] G = 1166, n = 5, rm = 1.75, Su et al. [102] G = 789.3, n = 9, rm = 1.24.
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model and G = 22.12.
3.7 Conclusion
The analysis of this paper leads to five important conclusions.
• The standard pseudo-steady model is not valid for early times. The definition of
early time depends on the experimental conditions but, as has been noted by many
researchers, there is a clear shift in the trend of the growth data: results prior to this
shift constitute the early time. Only in the second stage may the pseudo-steady model
be applied. In fact this is hardly surprising. The assumption of smooth spherically
symmetric growth is far from realistic at early times, when the addition of new atoms
or ’blobs’ together with the presence of a co-ordinating solvent will ensure that the
initial growth is not well approximated by a symmetric growth model.
If all growth data obtained from an experiment, including that at early time, is used to
calculate the model parameters then these values will be incorrect and will not represent
the physical quantities.
• Within the assumptions of the standard pseudo-steady model it is not possible to
distinguish between diffusion or surface reaction driven growth. Consequently
researchers have been able to fit experimental data equally well assuming either one
as the dominant mechanism or retaining both.
• Within experimental error it is a simple matter to invert the well-known implicit
growth relation t = t(rp) to the more practically useful form rp = rp(t). This has
not previously been presented in the literature. In fact, assuming ak = bD then the
inversion is exact.
• At most the growth model can only determine two independent growth parameters. If
the maximum radius is known then the growth data determines just a single parameter.
Previous work where a number of parameters are calculated have redundant elements:
in Ref. [102] four parameters are calculated from the growth data, but ak ≈ bD and
rm ≈ a/b ≈ D/k (due to the use of fitting routines some accuracy is lost and therefore
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the relations are not exactly equal). Fitting to a single parameter is generally simpler
and more accurate. For example, with more fitting parameters it is more likely that
incorrect values are found: we presented an example where the parameters differed
from those of other studies by an order of ten in magnitude.
• Depending on the material or initial size of the crystal neglecting the variation of the
particle solubility can be highly inaccurate. This error has not been picked up before
due to the fact that, certainly in the experiments examined in the present paper, it
influences the results during the initial growth stage when the pseudo-steady model
is incorrect anyway.
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Abstract
A mathematical model for the growth of a single nanocrystal is generalised to deal with
an arbitrarily large number of crystals. The basic model is a form of Stefan problem,
describing diffusion of monomer over a moving domain. Various levels of approximation
(an analytical solution, an ordinary differential equation model and an N particle model)
are compared and shown to agree well. The N particle model and analytical solution are
then shown to have excellent agreement with experimental data for the growth of CdSe
nanocrystals. The theoretical solution clearly shows the effect of problem parameters on
the growth process and, significantly, that there is a single controlling group. By increasing
the value of N it is shown that in the absence of Ostwald ripening the single particle model
may be considered as representing the average radius of a system with a large number of
particles. Consequently a system with N = 2 may represent either a two particle system or
a bimodel initial distribution. The solution of the N = 2 model provides an understanding
of Ostwald ripening. In general if Ostwald ripening is expected some form of the N particle
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model should be employed. Finally it is shown how the analytical solution may be employed
to represent a multi-stage growth process which can then guide and optimise crystal growth.
4.1 Introduction
Nanoparticles (NPs) are small units of matter with dimensions in the range 1-100 nm.
They exhibit many advantageous, size-dependent properties such as magnetic, electrical,
chemical and optical, which are not observed at the microscale or larger [11, 46, 74, 105].
Consequently the ability to produce monodisperse particles that lie within a controlled size
distribution is critical.
There exist a number of NP synthesis methods, including gas phase and solution based
synthesis techniques. Although the first method can produce large quantities of
nanoparticles, it produces undesired agglomeration and nonuniformity in particle size and
shape. Precipitation of NPs from solution avoids these problems and is one of the most
widely used synthesis methods [69]. The typical strategy is to cause a short nucleation
burst in order to create a large number of nuclei in a short space of time, and the seeds
generated are used for the latter particle growth stage. The resulting system consists of
varying sized particles. Small NPs are more unstable than larger ones and tend to grow or
dissolve faster. Thus at relatively high concentrations size focussing occurs (leading to
monodispersity). When the concentration is depleted by the growth some smaller NPs
shrink and eventually disappear while larger particles continue to grow, thus leading to a
broadening of the size distribution (which involves the process of Ostwald ripening).
Ostwald ripening is the process whereby smaller crystals dissolve and the material from
these crystals is redeposited onto the larger ones. Hence, below a certain size the crystals
start to decrease in size until they disappear, while larger crystals increase in size.
Perhaps the most well-known example of Ostwald ripening is the coarsening of crystals in
ice cream, giving a different texture to old ice cream. Depending on the system Ostwald
ripening can be rapid or very slow, as in the famous experiment of Faraday in the 1850’s
using colloidal gold which is still optically active.
The particle size distribution (PSD) can be refocused by changing the reaction kinetics.
For example, Peng et al. [90] observed size focusing during Cadmium Selenide growth
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following the injection of additional solute. Bastús et al. [10, 9] were also able to induce
size focusing of gold and silver nanoparticles by the addition of extra solute and adjusting
the temperature and pH. This type of technique for size focussing is still rather ad hoc in
that the precise relationships between particle growth, system conditions and the final PSD
are not fully understood [97]. Hence, in practice, the optimal reaction conditions are usually
ascertained empirically or intuitively.
In the 1960’s Lifshitz and Slyozov [62] and, independently, Wagner [115] were amongst
the first to provide theoretical descriptions of Ostwald ripening. Their classical theory,
hereafter referred to as LSW theory, consisted of a system of three coupled equations:
a growth equation for a single particle, a continuity equation for the PSD and a mass
conservation expression for the concentration. They solved the model to obtain pseudo-
steady-state asymptotic solutions for the average particle radius and PSD. Lifshitz and
Slyozov [62] focused on diffusion-limited growth, where growth is limited by the diffusion
of reactants to the particle surface, while Wagner [115] considered growth limited by the
reactions at the particle surface. In fact recent work described by Myers and Fanelli [79]
has shown that, within the restrictions of the steady-state assumption, the models cannot
distinguish between diffusion or reaction driven growth, so both approaches are equally valid.
For this reasons authors using either mechanism, or both, have been equally successful in
approximating experimental data.
Experimental studies on NP growth [23, 85, 102] show that LSW theory may provide
good predictions for the particle size but the observed PSDs are typically broader and more
symmetric. Possible explanations for this disparity is that LSW theory does not account
for the finite volume of the coarsening phase φ, and that it assumes a particle’s growth rate
is independent of its surroundings. In addition, LSW theory does not indicate how long it
takes to reach the final state. A further issue is that it purports to describe the dynamics in
the initial stages of the growth process. In [79] it is proven that the pseudo-steady solution
does not hold for small times.
Many studies have modified and built on the pioneering analysis of LSW theory. Ardell
[4] and Sarian and Weart [96] extended LSW theory to systems where the mean distance
between particles is finite. Several authors [14, 112, 113] have addressed the shortcomings
of LSW theory by statistically averaging the diffusional interaction of a particle of a given
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size with its surroundings to demonstrate that the resulting PSD becomes broader and more
symmetric with increasing φ. The inclusion of stochastic effects, due to temperature and
changes in concentration, in the modified population balance model of Ludwig et al. [67]
led to broader PSDs in line with experimental data. The population balance approach of
Iggland and Mazzotti [51] was used to examine the evolution of non-spherical particles at
the beginning of growth.
Most of the above studies were in relation to micron or larger-sized particles. As
measurement techniques have advanced many researchers have applied LSW theory and
the related modifications to the study of nanoparticle growth. Talapin et al. [104] used a
Monte Carlo approach to simulate the evolution of a nanoparticle PSD subject to
diffusion-limited growth, reaction-limited growth and mixed diffusion-reaction growth. In
contrast to other treatments, their simulations gave PSDs narrower than those predicted
by LSW theory. This was explained by the fact that they considered much smaller
particles. Their main conclusion was that Ostwald ripening occurs much more rapidly for
nanoparticles while PSDs are narrower than in their microscale counterparts. Similarly,
Mantzaris [69] used a population balance formulation and a moving boundary algorithm
to study the diffusion and reaction-limited growth regimes.
Another issue which is particularly relevant in the context of nanoparticles is the
applicability of the Ostwald-Freundlich condition which relates the radius of the particle,
r∗p, to its solubility, s∗. This condition can be written as
s∗ = s∗∞ exp
{(
2σVM
r∗pRGT
)}
≡ s∗∞ exp
{(
α
r∗p
)}
, (4.1)
where s∗∞ is the solubility of the bulk material, σ the interfacial energy, RG the universal
gas constant, T the absolute temperature. The capillary length α = 2σVM/(RGT ) defines
the length scale below which curvature-induced solubility is significant [104]. This
equation shows that the particle solubility increases as the size decreases (which promotes
Ostwald ripening). One approximation to the Ostwald-Freundlich condition is to assume
that the exponential term in (4.1) can be linearised to give the two term expression
s∗ ≈ s∗∞(1 + α/r∗p)[62, 63, 103, 115]. Obviously this expansion, which is based on α/r∗p, is
invalid for nanoparticles where the capillary length is of the same order of magnitude as
the particle radius [79]. Mantzaris [69] used an expansion for the exponential term in the
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Ostwald-Freundlich condition with n terms and showed that increasing n led to higher
average growth rates and a narrowing of the PSD. However, when comparing his
simulation to experimental data for CdSe nanoparticles from [89], he applied a linear
version for the solubility. Talapin et al. [104], noting that for nanoparticles of the order
1-5 nm the linearised Ostwald-Freundlich condition may be incorrect, applied the full
condition.
In the following we begin by analysing the growth of a single particle. This is the basic
building block for more complex models. The treatment leads to equations similar to those
of standard LSW theory, however we arrive at them following a non-dimensionalisation
which highlights dominant terms and those which may be formally neglected. In this way
we can ascertain which standard assumptions are appropriate and, more importantly, which
are not. Under conditions which appear easily satisfied for nanocrystal growth the governing
ordinary differential equation has an explicit solution, in the form rp = rp(t) and also shows
that the growth is controlled by a single parameter which may be calculated by comparison
with experiment. This section closely follows the work described in [79]. The single particle
model is obviously incapable of reproducing Ostwald ripening, where larger particles grow
at the expense of smaller ones. Consequently we then generalise the model to deal with a
large number of particles. In the results section we compare the analytical solution with
that of a full numerical solution and experimental data for the growth of a single particle
and show excellent agreement between all three. By setting the number of particles to two
in the general model we are able to clearly demonstrate Ostwald ripening. Simulations
with N =10 and 1000 particles demonstrate that increasing N leads to increasingly good
agreement between the average radius and that predicted by the single particle model. The
single particle model may thus be considered as a viable method for predicting the evolution
of the average radius of a group of particles.
4.2 Growth of a single particle
As shown in Figure 4.1, we initially focus on a single, spherical nanoparticle, with radius r∗p
in a system of particles. The ∗ notation represents dimensional quantities. The assumption
is that particles are separated at large but finite distances compared to their radius. Their
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morphologies remain nearly spherical and particle aggregation is neglected. Thus, the mass
flow from each particle can be represented as a monopole source located at the center of
the particle [111] and the problem becomes radially symmetric. We assume the standard
La Mer model [58], such that there has been a short nucleation burst and the system is now
in the period of growth.
Figure 4.1: Schematic of a single nanoparticle with radius r∗p and the surrounding monomer
concentration profile where s∗, c∗i and c∗b are the particle solubility, the concentration at the surface
of the particle and the far-field concentration, respectively.
The monomer concentration, c∗, is described by the classical diffusion equation in
spherical coordinates
∂c∗
∂t∗
=
D
r∗2
∂∗
∂r∗
(
r∗2
∂c∗
∂r∗
)
. (4.2)
This holds in the diffusion layer [r∗p, r∗p + δ∗] where r∗ is distance from the centre of the
particle, t∗ is time and D is the constant diffusion coefficient. To conform with standard
literature (see for example [69, 103, 108]), we have included a diffusion layer of length δ∗
around the particle, where the concentration adjusts from the value at the particle surface
to the value in the far-field. Equation (4.2) is then subject to
c∗(r∗p, t
∗) = c∗i (t
∗) , c∗(r∗p + δ
∗, t∗) = c∗b(t
∗) ,
c∗(r∗, 0) = c∗b,0 forr
∗
p < r
∗ < r∗p + δ
∗,
(4.3)
where c∗i is the concentration adjacent to the particle surface, c
∗
b is the concentration in the
far-field and c∗b,0 = c
∗
b(0) is a constant describing the initial concentration when the solution
is well-mixed (and the crystal is at the initial size r∗p(0)). The value at the particle surface
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c∗i is very difficult to measure [103], hence it is standard to work in terms of the particle
solubility.
The particle solubility s∗ (with the same dimensions as concentration) is given by the
Ostwald–Freundlich condition (4.1). If s∗ < c∗b then monomer molecules diffuse from the
bulk towards the particle to react with the surface and the particle grows, whereas if s∗ > c∗b
the particle shrinks.
In order to determine an expression for the concentration at the particle surface, we
consider two equivalent relations for the mass flux at the particle surface, J . Firstly, Fick’s
first law states that the flux of monomer passing through a spherical surface of radius r∗ is
J = 4pir∗2D
∂c∗
∂r∗
. (4.4)
At the surface of the sphere the flux must also follow a standard first order reaction equation
J = 4pir∗2k(c∗i − s∗) , (4.5)
where k is the reaction rate, which is assumed to be constant for both growth and dissolution
contributions. Equating (4.4) with (4.5) gives
c∗i = s
∗ +
D
k
∂c∗
∂r∗
∣∣∣∣
r∗=r∗p
, (4.6)
which defines the concentration c∗i for the surface condition of (4.3).
To complete the boundary conditions in the system, we require an expression for the
time-dependent bulk concentration, c∗b(t
∗). Mass conservation of the monomer in the
particle and in the surrounding solution is
1
N0
Mpc
∗
0 = Mpc
∗
b(t)
[
1
N0
− 4pi
3
r∗p
3
]
+
4pi
3
ρpr
∗
p
3, (4.7)
where c∗0 is the initial monomer concentration (measured before seed crystals appear), ρp
is density, Mp is molar mass and N0 the population density. The left hand side represents
the mass of monomer in the volume to be occupied by the single crystal. The right hand
side contains two components, the first is the mass of monomer in the solution surrounding
the crystal (this volume consists of the original region minus the volume occupied by the
crystal). The second component is the mass of the crystal. If the system is dilute then
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4piN0r
∗
p
3/3 1. Writing the molar volume VM = Mp/ρp, equation (4.7) then leads to
c∗b(t) ≈ c∗0 −
4piN0
3VM
r∗p
3 , (4.8)
which will be used to represent the far-field concentration in (4.3).
The diffusion equation must be solved on a domain r∗ > r∗p, where the particle radius
is an unknown function of time. The flux of monomer to the particle is responsible for the
particle growth
VMJ =
d
dt∗
(
4
3
pir∗p
3
)
= 4pir∗p
2dr
∗
p
dt∗
. (4.9)
Eliminating J between (4.9) and (4.4) yields
dr∗p
dt∗
= VMD
∂c∗
∂r∗
∣∣∣∣
r∗=r∗p
, (4.10)
which describes the particle radius evolution. Equation (4.10) is subject to the initial
condition r∗p(0) = r∗p,0, where r∗p,0 is the initial particle radius. The combination of the
diffusion equation, (4.2), describing the monomer concentration which is solved over a
moving domain, determined by equation (4.10), indicates that we are dealing with a
Stefan problem. The classical Stefan problem models phase change due to temperature
variation and so is described by the heat equation with the boundary defined by an energy
balance. The phase change temperature is a specified constant. Since we do not consider
the monomer concentration within the crystal while the interface concentration c∗i (t
∗) is a
function of time our model is mathematically equivalent to a one-phase Stefan problem
with a supercooled liquid phase (also termed undercooled). A Cartesian version is studied
in [35]. A similar two-phase problem is studied in [36] which deals with spherically
symmetric nanoparticle melting, with a size-dependent melting temperature. In this case
it may be seen that as the particle shrinks the boundary condition acts to speed up the
melting process, in the limit of the radius tending to zero the shrinkage rate tends to
infinity. In the present case the crystal is growing, hence the boundary condition acts to
slow down the growth (as compared to a fixed concentration condition). The standard
Stefan problem is highly nonlinear, with a single exception, exact solutions have little
physical application. In the present case of a non-standard problem no exact solution is
available.
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The governing system is now fully defined and consists of equation (4.2), subject to the
initial and boundary conditions (4.3), where c∗i is defined by (4.6) and c
∗
b by (4.8), and the
unknown particle radius satisfies (4.10). As widely known, there are a very few practically
useful exact solutions to moving boundary problems due to the non-linearity caused by the
Stefan condition. A general approach involves the use of approximate methods in order to
analyse Stefan problems when no analytical solution exists, as in this case. Therefore, we
proceed to simplify the problem and use numerical approximations in order to understand
the behaviour of the solution.
4.2.1 Nondimensionalisation
The model is nondimensionalised via
r =
r∗
r∗p,0
, rp =
r∗p
r∗p,0
, t =
t∗
τ∗
, c =
c∗ − s∗0
∆c
, s =
s∗ − s∗0
∆c
, (4.11)
where ∆c = c∗b(0) − s∗0 represents the driving force for particle growth, s∗0 = s∗(0) =
s∗∞ exp
{
(α/r∗p,0)
}
is the initial particle solubility. The concentration and growth equations
yield two possible time scales τ∗D = r
∗2
p,0/D and τ∗R = r
∗2
p,0/(VMD∆c), respectively. To focus
on particle growth we choose the time scale τ∗ = τ∗R and the system is now transformed to
ε
∂c
∂t
=
1
r2
∂
∂r
(
r2
∂c
∂r
)
,
drp
dt
=
∂c
∂r
∣∣∣∣
r=rp
, (4.12)
c(rp, t) = s+ Da
∂c
∂r
∣∣∣∣
r=rp
, c(rp + ,.t) = cb(t) = c0 − βr3p , (4.13)
c(r, 0) = 1 , rp(0) = 1 , (4.14)
where
ε = VM∆c , δ =
δ∗
r∗p,0
, Da =
D
kr∗p,0
,
ω =
α
r∗p,0
, β =
4piN0r
∗3
p,0
3VM∆c
, c0 =
c∗0 − s∗0
∆c
. (4.15)
The above system contains a number of nondimensional groups. The first, ε, is generally
very small for nanoparticle growth. For example, Peng et al. [89] studied Cadmium Selenide
nanoparticles, with a capillary length of 6nm and initial radii in the range 1 − 100 nm, so
that ε = O(10−3). In general it should be expected that ε  1. If we look at the time
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scales, we see that τ∗D/τ
∗
R = VM∆c = ε 1. Physically, this indicates that growth is orders
of magnitude slower than the diffusion time scale, that is, the concentration adjusts much
faster than growth occurs and so the system can be considered as pseudo-steady. In terms
of the mathematical model, this means that the time derivative can be omitted from the
concentration equation, but since time also enters into the problem through the definitions
of rp and cb this is a pseudo-steady-state rather than a true steady-state.
The parameter Da is an inverse Damköhler number measuring the relative magnitude
of diffusion to surface reactions [69]. In the past similar models have been simplified by
considering diffusion-limited growth (Da 1) or surface reaction limited growth (Da 1).
In practice both mechanisms play a role. So, we will place no restrictions on Da.
A common simplification is to assume ω  1 which reduces the Ostwald-Freundlich
condition, (4.1), to a constant s∗ = s∗∞ or a linear approximation is used, see [63, 103]. This
significantly simplifies the analysis. However, for particles that have just nucleated or very
small nanoparticles ω is not small and the simplification is not appropriate. Despite the
large errors in the prediction of s∗ caused by the small ω assumption authors obtain good
matches to data. In [79] it is shown that this is because the pseudo-steady model is not
valid for early times when the particle is small. By the time the model is valid so is the
linearisation. Basically, the variation of s∗ plays a minor role in the study of the growth of
a single nanoparticle. However, this is not the case with multiple particles where Ostwald
ripening is driven by the delicate balance between the bulk concentration and the particle
solubility.
The reason why the pseudo-steady model is invalid at small times is due to the thickness
of the boundary layer δ(t). The model involves the assumption δ(t) rp yet initially, when
the fluid is well-mixed δ(0) = 0. Only when the boundary layer is sufficiently thick is it
reasonable to apply the pseudo-steady model. In [79] it is shown through comparison with
experiments that the initial stage can last for the order of 100s. The shift to the pseudo-
steady model can often be identified simply by looking at the trend in the data. In the
following we will present the model with the full Ostwald-Freundlich condition and then an
approximation where it is neglected. We will also neglect early data points when matching
to experimental data.
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4.2.2 Pseudo-steady state solution
Since ε = O(10−3) and all variables have been scaled to be O(1) neglecting terms of order
ε should result in errors of the order 0.1%. Consequently, we neglect the time derivative in
the diffusion equation and obtain the pseudo-steady state form
1
r2
∂
∂r
(
r2
∂c
∂r
)
= 0 . (4.16)
After integrating and applying the boundary conditions we obtain
c = −A
r
+B , (4.17)
where
A =
r2p(rp + ).(cb − s)
rp+. Da(rp + ).
, B = s+A
(
1
rp
+
Da
r2p
)
. (4.18)
There is no way to calculate δ(t) in the pseudo-steady approach. A time-dependent
treatment, such as that described in [78] is required. Hence the standard method is to
assume rp  δ, which reduces the concentration to
c = cb −
r2p(cb − s)
(rp + Da)r
. (4.19)
Note, provided δ(t)  rp the value of δ is irrelevant: we may neglect the time variation.
Substituting (4.17) into the growth condition (4.12) leads to
drp
dt
=
cb(rp)− s(rp)
Da + rp
=
c0 − βr3p − s(rp)
Da + rp
. (4.20)
Hence, the problem has been reduced to the solution of a single first-order ordinary
differential equation for rp. It is a highly nonlinear equation which must be solved
numerically. The assumption that rp  δ means it only holds for relatively large times.
Approximate solutions, in various limits, may be found in the literature. For example if
we take cb constant and ω sufficiently small for the linear approximation to the
exponential to hold then equation (4.20) may be integrated in the limits of large and small
Da. In [79] it is shown that for sufficiently large times, for a single particle, the variation
of eω/rp is small in which case equation (4.20) may be integrated analytically to find an
implicit solution of the form t = t(r). By identifying negligible terms they are able to
invert this to find an explicit solution, r = r(t) which depends on a single parameter,
rp =
rm
2
[
1 + 2f(rps) exp
(
t−ts
G
)−√−3 + 12f(rps) exp ( t−tsG )][−1 + f(rps) exp ( t−tsG )] , (4.21)
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where rm is the (non-dimensional) experimental maximum radius, ts is the time at which
the second growth stage is judged to have begun, rps the radius at this time and f(rps) =
(r2m+rmrps+r
2
ps)/(rm−rps)2. Provided ts is chosen within the later growth stage the choice
should not greatly affect the results. However, in general we would prefer to choose ts as
close to the switch between the initial and later stages as possible to maximise the number
of data points for the fitting. This is discussed in further detail in [79]. The unknown
parameter G is defined as
G =
1
6ab
ak + bD
akbD
, a3 = Vm(c
∗
0 − c∗eq) , b3 =
4
3
piN0 . (4.22)
Its value is obtained by comparison with experimental data. The parameter c∗eq is an
approximation. It is a constant which replaces the variable s∞ exp(α/rp), in [79] the
concentration at the end of the experiment is used to provide its value. Once G is
determined, then the diffusion coefficient (D), the reaction rate (k), the solubility of the
bulk material (s∞) and population density (N0) may be systematically retrieved. In [79] it
is stated that ak ≈ bD, hence G ≈ 1/(3a2bk) = 1/(3ab2D). Further, since c∗0  c∗eq a
reasonable approximation is a3 = Vmc∗0. Growth stops when the maximum radius
r∗m = a/b is achieved.
4.3 Evolution of a system of N particles
We now extend the above single particle model to a system of N particles where N is
arbitrarily large and may decrease with time due to Ostwald ripening. The particle radii,
initial radii and solubilities are denoted r∗i , r
∗
i,0 and s
∗
i , respectively, where i = 1, . . . , N
represents the ith particle. We nondimensionalise via (4.11) with the only difference being
that the length scale r∗p,0 is replaced by the mean value r¯∗i,0 = Σi=1..N (r
∗
i,0/N). It has to
be noted that this affects the concentration scale through the initial solubility which now
becomes s∗i,0 = s
∗∞e
α/r¯∗i,0 , then ∆c = c∗b,0 − s∗i,0. Hence in what follows, all dimensionless
parameters defined in equation (4.15) carry an overbar to reflect the change in length scale.
Under the pseudo-steady approximation and assuming that there are no interparticle
diffusional interactions, the growth of each particle is now described by an equation of the
form (4.20). This requires an expression for the bulk concentration which must account for
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the fact that all particles remove monomer and that the volume is now N times that of the
single particle
N
N0
Mpc
∗
0 = Mpc
∗
b(t
∗)
[
N
N0
− 4pi
3
N∑
i=1
r∗i
3
]
+
4piρp
3
N∑
i=1
r∗i
3 . (4.23)
Again assuming that the solution is sufficiently dilute that (4piN0/3N)
N∑
i=1
r∗3i  1, we
obtain
c∗b(t
∗) ≈ c∗0 −
4piN0
3NVM
N∑
i=1
r∗3i . (4.24)
In the limit where all particles are identical
∑
i=1..N r
∗3
i = Nr
∗3
i and the single particle
model of equation (4.8) is retrieved. In dimensionless form the problem is then governed
by the system of differential equations
dri
dt
=
cb(ri)− s(ri)
Da + ri
=
c0 − (β/N)
∑N
i=1 r
3
i − s(ri)
Da + ri
(4.25)
for each i = 1, . . . , N and
Da =
D
kr∗i,0
, β =
4piN0r
∗3
i,0
3VM∆c
, c0 =
c∗0 − s∗i,0
∆c
s(ri) =
s∗∞
∆c
(
eω/ri − eω/ri,0
)
, ω =
α
ri,0
. (4.26)
Equation (4.25) represents a system of N non-linear ODEs which must be solved
numerically.
4.4 Comparison of model with experiment
Using the full numerical solution, defined by (4.12)–(4.14), on the N particles model would
be prohibitively expensive. For this reason the first goal of this section is to demonstrate that
the pseudo-steady state model of equation (4.20) is a good approximation to (4.12)–(4.14),
so justifying its use in our N particles model. We validate the models using experimental
data on CdSe nanocrystals synthesis taken from [89]. Certain parameter values concerning
the experiment and CdSe are provided in that paper, others, such as D, k, s∗∞, N0 must be
inferred. Here they will be determined through fitting to equation (4.21). Since this only
contains one free parameter the fitting is a very simple process.
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4.4.1 Parameter estimation via the analytical solution
In Figure 4.2 we show the first eleven data points from [89]. As discussed earlier not all
data points correspond to the pseudo-steady regime, here it is clear that the first three
points follow a linear trend so these will be neglected. In the experiment extra monomer
was added after three hours, so we have ignored all data beyond the eleventh point. Using
the remaining eight data points in the nonlinear least-squares Matlab solver lsqcurvefit to
fit to equation (4.21) we obtain G ≈ 958. To determine the necessary parameters for
the other models we first note that the maximum radius attained during this part of the
experiment is r∗m ≈ 3.8nm= a/b = D/k. The experimental concentration at the end of the
growth process is known, this defines c∗eq = s∗∞eα/r
∗
m ≈ 0.08 mol/m3. This together with
the definition G = rm/(3a3k) = r2m/(3a3D) and the information in Table 4.1 is sufficient to
determine D, k, s∗∞, N0. The values taken from [89] are shown as the first ten rows of Table
4.1, the final four (in italics) are the ones calculated after G has been determined.
The result of equation (4.21), with G = 958, is shown as the solid line in Figure 4.2.
The dashed line represents the result predicted by the PSS model. Clearly there is excellent
agreement between the two as well as with the data. This verifies the claim that the
solubility may be set to a constant without greatly affecting the solution (provided the
early time data is neglected).
Figure 4.2: The circles represent the experimental data from Peng et al. [89] and the solid line
the corresponding least-squares fit to the analytical solution, equation (4.21) with G = 958. The
dashed line is the PSS model with the same value of G.
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Quantity Symbol Value Units
Universal gas constant RG 8.31 J mol−1 K−1
Density ρp 5816 kg.m−3
Molar volume VM 3.29× 10−5 m3 mol−1
Molar mass Mp 0.19 kg mol−1
Solution temperature T 573.15 K
Surface energy σ 0.44 J mol−2
Capillary length α 6.00× 10−9 m
Initial bulk concentration c∗0 55.33 mol m−3
Volume of the liquid V 7.21× 10−6 m3
Maximum particle radius rm 3.78× 10−9 m
Diffusion coefficient D 3.01× 10−18 m−2 s−1
Reaction rate k 7.97× 10−10 m s−1
Solubility of bulk material s∗∞ 5.53× 10−2 mol m−3
Population density N0 8.04× 1021 No. m−3
Table 4.1: Physical parameters for the cadmium selenide (CdSe) nanoparticle synthesis method
used by Peng et al. [89]. The parameters in italics are not given explicitly and are obtained via a
fitting approach.
4.4.2 Validating the pseudo-steady state approximation
The PSS model is described by equations (4.17)-(4.20). Since this forms the basis for the
N particle model it is important to verify its accuracy. We do this by comparison with the
numerical solution of the full system (4.12)-(4.14) (referred to as the full model). Although
we have already shown that the PSS is very well approximated by the analytical solution
and that for a single crystal the solubility variation may be neglected, we must employ the
PSS in the N particle model. This is because when an individual particle’s solubility drops
below the bulk concentration Ostwald ripening occurs. The analytical solution neglects
variation in solubility, so cannot capture this behaviour.
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Problems similar to the full model frequently occur in studies of phase change where it is
termed the one-phase Stefan problem (one-phase because the temperature is neglected in one
of the phases, this is analogous to neglecting the concentration in the crystal). Examples of
one-phase problems occur in laser melting and ablation, Leidenfrost evaporation of a droplet
and in supercooled materials. At the nanoscale there are many studies on nanoparticle
melting and growth, see [33, 34, 81]. The nanoparticle studies are particularly relevant,
since they deal with a spherical geometry and at the nanoscale the melt temperature varies
in a manner similar to the variation of the solubility in the current problem. For this reason
we follow the numerical scheme outlined in the studies of [33, 34]. For the numerical solution
we choose a large, fixed domain (equivalent to stating δ is large and constant). The scheme
involves a standard boundary immobilization transformation and then a semi-implicit finite
difference scheme is applied to the resulting equations. The PSS model requires the solution
of a single nonlinear ordinary differential equation, (4.20). To do this we simply use the
Matlab ODE solver ode15s. Once rp is determined the concentration is given by equation
(4.19).
(a) (b)
Figure 4.3: Solution of the full and the PSS models (represented by circles and by a solid line,
respectively) for the growth of a single particle. Panel (a) shows the evolution of the particle radius
and panel (b) the concentration of monomer around the particle at five different times.
In Figure 4.3 we compare the numerical solution of the full and PSS models using the
parameters of Table 4.1, where panel (a) shows the evolution of the particle radius and
panel (b) the concentration profile at five different times. In both cases the agreement
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between the full and PSS models is excellent, thus justifying the use of the simpler PSS
model in the N particle system. All subsequent calculations will be based on the PSS model.
Panel (a) shows how the particle grows rapidly until around t ≈ 1 hr when the growth rate
decreases, subsequently the radius slowly approaches the maximum value of rp ' 3.8 nm.
This behaviour can be understood by analysing the concentration profiles presented in panel
(b). The growth rate is proportional to the concentration gradient adjacent to the particle.
From Figure 4.3(b) it is clear that the concentration gradient near the particle surface is
relatively large at small times, leading to rapid growth. After t ≈ 1 hr the concentration
profile is practically flat, resulting in a slow growth rate.
4.4.3 Ostwald ripening with N = 2
With the single particle model the growth rate tends to zero as the solubility and bulk
concentration approach each other. Initially all terms on the right hand side of Eq. (4.20)
are positive, indicating a positive growth rate. The increase in rp leads to a decrease in
bulk concentration and the growth rate tends to zero as this concentration approaches the
solubility. The analytical solution indicates that this approach is exponential and there
is no mechanism for the growth rate to become negative. Hence Ostwald ripening, where
a particle has a negative growth rate can only occur in a system with more than one
particle. For certain materials Ostwald ripening may take a very long time and so be
difficult to observe. Faraday’s experiment shows time-scales on the order of decades, in [25]
a broadening of the CdSe particle radii on the order 0.1nm occurs over a period of hours.
To demonstrate that the current model can predict Ostwald ripening we now investigate
the simplest possible case, with two particles. However, since we are using data for CdSe
we anticipate a slow process.
The system is defined by equation (4.25) with N = 2. We take parameter values from
Table 4.1 and choose initial radii 2 nm and 2.5 nm. The two governing equations may be
easily solved using the Matlab ODE solver ode15s. Results are presented in Figure 4.4. The
first figure shows the evolution of the radii for more than 25 hours. The solid line represents
the evolution of the 2.5 nm particle, the dashed line is the 2 nm one. As can be seen, for
small times both particles grow rapidly however, after around 1.7 hours the smaller particle
starts to shrink, while the larger one grows linearly. In Figure 4.4(b) the variation of the
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particle solubility and concentration is shown, solid and dashed lines correspond to the 2.5,
2nm particle’s solubility respectively, while the dotted line is the bulk concentration. With
reference to the variation of the radius it is clear that the rapid growth phase corresponds
to a sharp decrease in the bulk concentration. Initially the solubility of each particle is
below the bulk concentration and decreases as rp increases. Ostwald ripening begins when
the solubility of the smaller particle crosses the cb curve, at t ' 1.7h, and subsequently its
size decreases. The solubility of the larger particle keeps slowly decreasing, in keeping with
its slow growth, and remains below the bulk concentration until the end of the simulation.
If we continued the simulation the smaller particle would eventually disappear, the rate of
decrease in radius increasing with time.
(a) (b)
Figure 4.4: Evolution of two CdSe nanoparticles. (a) Change in time of the radii of two particles
with initial radii of 2 nm (dashed line) and 2.5 nm (solid line). (b) Change in bulk concentration
(dotted line) and solubilities of smaller (dashed line) and larger (solid line) particles.
4.4.4 N particles system
To simulate the experiments of [89] we consider a distribution of N nanoparticles where
the initial distribution is generated by random numbers, with an initial mean radius r¯∗i,0
of 2.92 nm and a standard deviation of σo = 8.9%. In the numerical solution if a particle
decreases below 2nm it is assumed to break up and all the monomer returns to the bulk
concentration.
In Figure 4.5 we compare the prediction for the average radius of 10 and 1000 CdSe
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particles (dashed lines) with the corresponding data of Peng et al. [89]. The single particle
analytical solution for r(t), equation (4.21), is shown as a solid line. The inset shows the
difference between the N particle and analytical solution. In Figure 4.5(a) the maximum
difference between the two solutions is of the order 1.5%, which decreases rapidly with time.
The solution with N = 1000, shown in Figure 4.5(b), has a maximum difference of the order
0.15% from the analytical solution.
(a) (b)
Figure 4.5: Comparison of the model for N particles (dashed lines) with experimental data from
Peng et al.[89] (dots) using N = 10 in (a) and N = 1000 in (b). The solid lines represent the explicit
solution for the one particle model, equation (4.21). The inset plots show the percentage difference
between the models.
In practice N would be much higher. In Table 4.1 the population density is given as
N0 = 8.04×1021 crystals/m3, so in a volume V ≈ 7×10−6m3 we would expect around 1016
crystals. The figure demonstrates that as N increases the solution tends to the analytical
solution. Given that N is typically very high it is then clearly not necessary to solve the
large system: the analytical solution is easier to understand and implement than a 1016
particle model. However, it is important to note that in the present example there is no
significant Ostwald ripening. From Figure 4.4 we observe defocussing starts around 1.7
hours and after nearly 30 hours the radius of the smaller particle has only decreased by
7%. In the experimental data used here extra monomer is added to the solution after three
hours and we stop our simulation then. So, in the absence of significant Ostwald ripening
we may assume that the analytical solution may be used to predict the average evolution
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of nanocrystal growth. In situations where Ostwald ripening is to be modelled some form
of N particle model should be used, since this accounts for the solubility of each particle.
4.4.5 Optimal strategies for growth
For commercial applications crystal growth is a multi-stage process, with extra monomer
being added whenever it is judged that the concentration is low. Generally this is an ad-hoc
process, with no clear rules on when or how much to add. The solutions provided in the
present study can help to inform this process.
Firstly, we note that equation (4.20) indicates a maximum growth rate when cb − s is
maximum. This suggests maintaining a high bulk concentration. However, if too much
is added the concentration will surpass the saturation level, leading to the nucleation of
small crystals and a possible, undesirable, bimodal size distribution. This may be avoided
since the radius is known, via equation (4.20), so the bulk concentration cb ≈ c0 − βr3p
is also known. Hence at any given time we know how much monomer is in solution and
consequently how much may be added.
In theory a continuous drip, which matches the rate at which monomer is lost, could be
used to replace monomer and maintain the concentration at a constant high level. In practice
monomer is usually added in distinct stages, our solution can determine the maximum
possible amount. However, it must be noted that when using the present method, at each
injection new initial conditions must be applied. This means that the initial radius for, say,
the second stage would be the value at the end of the first stage and the initial time that of
the injection. The value of a must be adjusted since the new initial concentration will be
what remains at the end of the first stage plus what is added. This value then affects the
value of G.
In Figure 4.6 we show the evolution of the radius for an experiment with similar
conditions to those studied in Peng et al. [89]. Hence all parameter values from Table 4.1
are kept the same, with the single difference that we start with a value c∗0 = 50 mol/m3
and add 50 and 100 mol/m3 at different times. The solid curves have an addition at 0.25
and 0.5 hours, the dashed curves after 1, 3 hours. In both cases the final radius is around
5.8nm, but in the first case this is achieved after 2 hours, in the second close to 5 hours.
4.5. Conclusions 65
0 1 2 3 4 5 6
2.5
3
3.5
4
4.5
5
5.5
6 10
-9
rp (nm)
t (hours)
Figure 4.6: Evolution of the radius varying the time of further injections.
4.5 Conclusions
We have developed a model for the growth of a system of N particles, where N may be
arbitrarily large. The model involves a system of first order nonlinear ordinary differential
equations, which are easily solved using standard methods. The basis of the N particle
model is the pseudo-steady approximation presented in [79] which was shown to be an
excellent approximation to the full numerical solution. This model incorporates the particle
solubility variation which then permits the model to capture Ostwald ripening.
The main drawback to a single particle model is that it cannot describe Ostwald ripening.
By studying the system with N = 2 we were able to emulate Ostwald ripening on a very
simple system. The method can be easily translated to any number of crystals.
By allowing N to become large and calculating the average particle radius we showed
that the results approached the single particle explicit solution, which may thus be
considered to represent the average growth of a large distribution of particles. A
consequence of this is that the N = 2 model can equally well represent the average radii
for an initially bimodal distribution of nanocrystals. An N > 2 model can represent a
much larger distribution of particles.
The main advantage of the current method is that since the single particle model may be
solved analytically, and this accurately describes the average radius of a distribution, then
the controlling parameters are apparent. This allows us to adjust them and so optimise the
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growth process. The method is easily adapted to multi-stage growth. Provided Ostwald
ripening is prevented, which is the usual procedure in a controlled environment, we only
have to deal with a single particle so the solution is rapid (almost instantaneous), as opposed
to previous large scale, time-consuming calculations.
In future work we intend to combine this with a detailed experimental study to derive
appropriate guidelines for nanocrystals production.
Part II
Drug delivery at the nanoscale
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5 | Magnetic drug targeting
5.1 Introduction
Currently the main approaches in cancer therapy include surgery, chemotherapy,
radiotherapy and hormone therapy [6]. However, since the latter three are non-specific
their efficacy is not only reduced but sometimes the cure is more aggressive than the
disease itself. There are two major disadvantages of a non-specific therapy for cancer
treatment: first of all, the systemic distribution of the drug normally generates several
side effects as the drugs attack healthy cells in addition to the tumour cells; secondly, the
high dosage of drugs required to target malignant cells. The goal of improving the efficacy
of the therapy was widely studied by researchers in the late 1970s, who proposed to use
magnetic carriers to target specific areas where the disease was concentrated [86]. In order
to specifically target tumours there are currently two standard techniques. The first
involves the inhibition, by various means, of drug delivery to healthy non-cancerous cells
while the second involves the direct conduction of drugs into the tumour site. It is now
accepted that one way to achieve the second technique is by using nanoparticles to deliver
the drugs directly to the tumour cells which results in minimum drug leakage into normal
cells [118]. The technique of magnetically targeted drug delivery involves binding a drug
to small biocompatible magnetic nanoparticles, injecting them into the bloodstream and
then using a high gradient magnetic field to direct them to the target region. Once they
arrive to the endothelium part near the tumour, they diffuse into the tumour tissue
through and deliver the encapsulated drug molecules into tumour sites [121].
The interest in the nanoscale began thanks to the discovery that tumours have a highly
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porous vasculature which allows access to nano-sized particles delivering therapeutic agents
[91]. There are several types of structures, called nanovectors, that can be filled with
anticancer drugs or can be used to attach molecules to their surface. Both methods are used
for in vivo visualization of markers of diseases and targeted delivery of therapeutic agents
in order to reduce collateral effects. The first example of successful nanovectors containing
inorganic nanoparticles, like gold, are a particular lipid system called liposomes. They are
FDA-approved and nowadays widely used for breast cancer treatments [87], and represent
the first generation of a huge field of on-going development of drug carriers [56, 88]. A
particularly interesting case is the one of metal-based nanovectors, called nanoshells, which
are composed of a silica core surrounded by a gold layer. As explained in the first part of this
thesis, gold nanoparticles can be precisely tuned in order to reach the result desired: in this
case this property is used to build a gold layer of different thickness that can be selectively
activated through tissue irradiation for therapeutic thermal ablation, a procedure widely
performed in cancer therapy which uses heat to remove tissue by burning it [5]. In fact, each
colour can be conjugated with antibodies to different molecular targets and, when irradiated,
a precise map of the distribution of many molecular markers is generated [31]. Moreover,
the size of the particle is crucial in the margination dynamics, which is the movement of
particles in the flow toward the walls of a channel, due to the risk of being filtered out of
the blood or via extravasation from a tumour [19]. It has been shown by Decuzzi et al.
[27] how particles used for drug delivery should have a radius smaller than a critical value
(which is ≈ 100nm) to facilitate margination and interaction with the endothelium, as a
result of the balance of the forces acting on the particles.
However, there are several open questions in this novel technique. From a chemical
point of view, the toxicity released by nanoparticles injected in the body and the possibility
of embolization of the blood vessel in the target region due to accumulation of magnetic
carriers are major concerns [28]. Moreover, the characteristics of the external magnetic field
(like intensity and position) is also still a topic of discussion, but it is widely recognised
that it can be used only with tumours near the surface of the body and not too far from the
target site [98]. At the present, there are many promising studies, both in vivo and in vitro
[2, 75, 116]. To our knowledge, only a few successful trials for magnetically drug delivery
on human patients have been carried on. A first study conducted a trial on 14 patients
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with advanced tumours unsuccessfully treated with other methods [66]; a second one used
this technique in order to improve the delivery of a magnetic targeted chemotherapy agent
in the treatment of inoperable hepatocellular carcinoma [117]; finally, in the same year 11
patients were examined with MRI before and after magnetic drug targeting [61]. All this
experimental studies have shown that, under particular circumstances, magnetic forces can
attract particles in the region near the magnet but there is a lack of knowledge about the
mechanism of this accumulation [32]. For this reason it is still difficult to scale-up the results
from small animals to human.
The focus of this chapter is based on physical aspects of this technique, and in particular
the delicate balance of the hydrodynamic and magnetic forces which cause the movement
and directing of the particles in drug delivery systems while modelling the blood as a non-
Newtonian fluid. The goal is to reach a deep understanding of the process in order to
optimize the success of the therapy by controlling the motions of the nanoparticles in the
bloodstream.
In the past, several authors studied the movement of particles subjected to a magnetic
field in the bloodstream considering different models for the flow of the blood. In order to
simplify calculations most of them used the approximation for a Newtonian fluid or the very
popular power-law model. Moreover, previous studies worked mostly at microscale, which
has the advantage to respond strongly to the external magnetic field (since magnetic force
scales with particle volume [82]), but in this case particles tend to agglomerate during the
delivery. Grief and Richardson [45] and then Richardson et al. [94] developed a continuum
model for the motion of particles subjected to a magnetic field, both using a Newtonian
flow model for the blood. In [45] it was shown, via a simple network model, that it is
impossible to specifically target interior regions of the body with an external magnetic field;
the magnet can be used only for targets close to the surface. The second work analysed
the boundary layers in which particles tend to concentrate during the delivery. Nacev et al.
[82] analysed this same process using a sophisticated numerical solver to simulate particle
behaviour under the influence of a magnetic field using a power-law assumption for the
flow of the blood in the vessels. Yue et al. [122] implemented a stochastic ODE model for
clusters of nanoparticles in a Hagen-Poiseuille flow in order to find the optimal injection
point. Cherry and Eaton [20] developed a comprehensive model for the motion of magnetic
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particles using a fitted value for the viscosity from experimental data given by Brooks et
al. [16] with a shear thinning model, then used a power-law expression for the behaviour
of the fluid in the case of a dilute suspensions of microscale particles suspended in blood.
Lunnoo and Puangmali [68] used a generalized power-law model for the rheology of the
blood in order to investigate the parameters which play a crucial role in the magnetic drug
targeting, showing how difficult it can be to keep small particles in the desired region.
More recently, Rukshin et al. [95] developed a stochastic system of differential equations in
order to simulate the behaviour of magnetic particles in small vessels, where the velocity
of the blood is described by a power-law profile. They claim to simulate the movement
of superparamagnetic nanoparticles, which have a radius smaller then 30nm, but then use
a value of the order of 10−7 for the simulations. Most of the literature shows that small
particles have a better chance to reach the target but a lack of accurate size determination
has been found in several studies [40]. In the same year, Boghi et al. [13] show a complete
numerical simulation of drug delivery in the blood in the coeliac trunk, where nanoparticles
are dragged into the liver by an external magnetic field, considering a Newtonian fluid.
The aim of this project is to analyse the forces and the parameters involved in the process
of magnetic drug delivery and to highlight the importance to consider realistic models for
both the flow of the blood and the motion of the nanoparticles in it. In particular, it is
crucial to consider the non-Newtonian behaviour of the blood in order to predict if particles
are able to reach the desired area. A mathematical model in a 2D channel is introduced in
Section 5.2. In Section 5.3, it is explained how choosing an oversimplified approximation
constitutive law for the fluid in the vessel or a wrong value for the viscosity in the centre
of the channel can lead to significant errors. Once obtained an accurate approximation for
the behaviour of the blood in the vessels, in Section 5.4 we show how magnetic forces act
on particles depending on their size. In fact, it is clear that in order to reduce the toxicity
of this method, particles need to be superparamagnetic and to lose their magnetism as
soon as the external magnetic field is removed. Numerical simulations by varying some key
parameters are presented in Section 5.5 and conclusions are drawn.
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5.2 A mathematical model for magnetic drug delivery
The physical process that we model here is related to the very promising technique of
magnetic drug targeting. Drugs bound to magnetic nanoparticles are injected into the
bloodstream and driven by an external magnetic field with the aim to reach the disease
area. In order to model this complex process, a clear understanding of the blood circulation
throughout the human body is needed. In Figure 5.1 it is shown how blood flows through
a system of vessels, called the circulatory system. As the heart beats, blood full of oxygen
and nutrients is carried away throughout the aorta, the main artery, to the tissues. Arteries
branch several times in arterioles which become smaller as they carry blood further from
the heart until becoming capillaries. At this point, they have thin walls which allow oxygen
and nutrients to pass through the tissue cells. Capillaries connect the arteries with the
veins, where blood flows back from the body to the heart. They become larger and larger,
from being venules to reach the size of the so-called vena cava, the largest vein that brings
the blood back into the heart. The average lengths (L) and widths (R) of the five types
by which blood vessels are classified can be found in Table 5.1, together with the values for
the aorta and the vena cava. Moreover, the average number of these vessels in the human
body (N) is given.
Figure 5.1: Different types of vessels in the circulatory system. Image credits to the U.S. National
Library of Medicine [92].
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Vessel L (m) R (m) N
Aorta 0.4 1.25× 10−2 1
Artery 0.1 1.5× 10−3 159
Arteriole 7× 10−4 2.5× 10−5 5.7× 107
Capillary 6× 10−4 4× 10−6 1.6× 1010
Venule 8× 10−4 1× 10−5 1.3× 109
Vein 0.1 2.5× 10−3 200
Vena cava 0.22 1.5× 10−2 2
Table 5.1: Typical values for the various types of vessels in human body: average length (L) and
width (R), estimation of the average number of a specific vessel in the circulatory system (N). All
values are adapted from [38].
The main assumption that we will make in order to simplify the system of equations is
that the width of the vessel is significantly smaller than its length. From the values in Table
5.1 it is clear that each type of vessel verify this property. Hence, this project is focused
on the simulation of magnetically drug delivery in an artery, since many of the parameters
needed for the simulation in this case have been extensively measured in literature and,
therefore, it is a good example for a realistic study. However the model can be easily used
to simulate different types of vessel since its dependence from their size is widely explained.
As represented in Figure 5.2, we approximate the vessel as a rectangular channel, with
the width significantly smaller than its length. We also assume that the magnetic particles
are injected from the left border and their motion is driven by the magnetic field generated
by a magnet located below the domain which counteracts the drag force on the particles
due to the blood.
A key issue in magnetic drug delivery is whether the applied magnetic forces can compete
with convective blood (drag) forces that tend to wash particles away. These drag forces have
different effects on the particle varying with the particles position in the blood vessel. A
particle at the vessel centerline will experience a higher drag force than a particle near the
wall, because the latter will be surrounded by a near zero blood velocity. The ‘no-slip’
condition is assumed at the walls, which means that the velocity of the blood is zero there.
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Figure 5.2: Sketch of the injection of magnetic nanoparticles in a vessel in the presence of red
blood cells and subject to an magnetic field.
Therefore, a particle near the vessel wall experiences a smaller drag force and is
attracted more severely by the magnetic field. Furthermore, the model takes into account
the interactions and collisions between moving red blood cells (RBCs) in the bloodstream
which cause a, so-called, shear-induced diffusive motion of the magnetic particles [45].
Moreover, the aggregation of RBCs strongly influences the blood flow characteristics,
being the major cause of the non-Newtonian nature of blood [53]. Brownian motion can
also be important due to the small size of the particles while gravity is assumed negligible.
We also have to pay attention to the rate at which the drug diffuses from the bloodstream
into the extravascular space, that is the permeability of the wall which varies according
to the types of the vessels. According to the definition of the Medical Subject Headings
(MeSH), the vascular permeability is the property of blood vessels that allows for the selective
exchange of substances between the blood and surrounding tissues and through membranous
barriers. This, however, is not easy to measure. Also, if the drug is lipid-insoluble, that is
capable of dissolving in fatty tissues, the capillary membrane permeability controls the rate
at which the drug is distributed between the blood and tissue regions. The distribution of
the drug is then said to be diffusion-rate limited [39].
Since blood containing nanoparticles can be considered a sort of nanofluid, its motion is
usually described by a coupled set of partial differential equations describing the fluid flow,
widely known as Navier-Stokes equations, and the particle concentration, whose behaviour
is described by an advection-diffusion equation. The general model describing the flow of a
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nanofluid in a vessel subject to an external magnetic field is then:
∇ · uF = 0, (5.1)
ρ
[
∂uF
∂t
+ uF · ∇uF
]
= −∇p+∇ · τ + FF , (5.2)
∂c
∂t
+∇ · [(uF + up)c] =∇ · (D∇c) , (5.3)
where uF is the fluid velocity, ρ is the fluid density, p is pressure, τ is the stress tensor, FF
the magnetic force acting on the fluid, c the particle concentration, up the particle velocity
and D the particle diffusion coefficient. In order to simplify the model for the blood flow
we will consider FF sufficiently small and we neglect it. In fact, even if it has been shown
that blood viscosity can reduce due to the magnetic field under certain circumstances (see
for example [106]), natural blood has negligible magnetization [3] and its overall character
is found to be paramagnetic [109]. On the wall of the vessel, the fluid obeys the no-slip
condition, while the particles are assumed to be able to pass through the vessel according to
some permeability coefficient κ. The particles are injected on the left of the domain (inlet)
during some injection interval Tinj, while the end of the vessel is sufficiently far from the
magnet that its effect is almost zero.
In the next sections, we will study the flow of the blood comparing different constitutive
laws in a vessel and their effect on the concentration of magnetic nanoparticles.
5.2.1 The magnetic field
The interest in magnetic nanoparticles as drug carriers stems from several of their properties
that are useful in medicine. The combination of the advantages of the small size with the
possibility to control them via an external magnetic field which can easily penetrate human
tissue makes them good candidates for drug delivery. However, an important question is
how near the magnetic field has to be to the target area in order to achieve the targeting.
In fact, since the magnetic gradient rapidly decreases with increasing the distance to the
target, alternative methods like implant magnets or ferromagnetic microwires has been used
as alternatives to external magnetic fields [68]. Moreover, the fact that due to this decreasing
in distance the area where magnetic forces can compete with drag forces is limited has been
one of the main difficulty in moving from animal to human trials [32].
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In order to evaluate the magnetic force acting on the particles in the vessel, let us
consider the Maxwell’s equations for stationary or slowly varying magnetic fields:
∇×H = j, (5.4)
∇ ·B = 0, (5.5)
B = µ0 (H+M) , (5.6)
where H is the intensity of the magnetic field B, j is the current density, µ0 is the
permeability of the vacuum and M is the materials magnetization. The magnetization is
usually correlated to the magnetic moment m = VmM, where Vm the volume of the
material, or it can be defined in terms of the magnetic susceptibility χ by the
Clausius–Mossotti formula for a spherical particle [95]
M =
χ
1 + χ/3
H. (5.7)
The susceptibility describes how the magnetization is induced in a material by the the
magnetic field. Most materials display little magnetism, with a low value of χ in the range
of [10−6, 10−1] in the case of paramagnets and depends not only on the temperature but
also on H. As mentioned earlier, the size of the magnetic particle plays a crucial role in this
physical process. In fact, only when the particle is smaller than a critical diameter (which
is about 30nm), does it exhibit superparamagnetic behaviour, which is the capacity of its
magnetization to be on average zero in the absence of an external magnetic field [68]. In
this case, the magnetic moment of the particle is free to fluctuate in response to thermal
energy while the individual atomic moments maintain their ordered state relative to each
other [86].
In order to exert a magnetic force on magnetic nanoparticles in the vessels, a magnetic
field gradient is required at a distance. We can define the magnetic force Fmag on a single
particle in a magnetic field B as
Fmag = (m · ∇)B, (5.8)
that is the derivative of the magnetic field B in the direction of m. One possible
approximation is to use the expression B = µ0H in order to rewrite equation (5.8) as
Fmag = Vmµ0 (M · ∇)H = 4pia
3
3
µ0χ
1 + χ/3
(H · ∇)H = 2pia
3
3
µ0χ
1 + χ/3
∇|H|2, (5.9)
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where a is the radius of the particle and (5.7) has been applied. Equation (5.9) shows
two important features of the magnetic force: first of all, it is proportional to the particle
volume, which makes the nanoscale case so different from the microscale; secondly, it is
proportional to the gradient of the magnetic field intensity squared, which is one of the
parameters compared in several studies.
In the particular case of superparamagnetic nanoparticles, the magnetic moment
depends on the local magnetic flux density and we can use the Langevin function
m =
msatB
|B| L(|B|) =
msatB
|B|
[
coth
(
msat|B|
kBT
)
− kBT
msat|B|
]
(5.10)
where kB is Boltzmann’s constant and T is the absolute temperature. The variable msat is
the magnetic saturation of the particle given by
msat =
4pia3
3
ρMsat, (5.11)
where ρ is the density of the magnetic particles and Msat is the mass saturation
magnetization. Grief and Richardson [45] have shown that for sufficiently weak fields on
superparamagnetic particles we can consider the approximation
Fmag ≈ m
2
sat
3kBT
(B · ∇)B = m
2
sat
6kBT
∇|B|2. (5.12)
Nacev et al. [82] have shown that for a magnet held at a long distance compared to the
width of the vessel, we can assume the magnetic force is approximately constant in the
vertical direction which avoid the need to solve Maxwell’s equations. Richardson et al. [94],
for example, use a constant value for the magnetic force given by
F0 =
4
3
pia3ρMΥBg, (5.13)
where Υ is the magnetite volume fraction and Bg is the gradient magnetic field. This is
what we are going to assume in this work.
5.3 Blood as a non-Newtonian fluid
If we imagine the flow of the blood in a reduced space, it is clear that its behaviour will
be more complex than a simpler fluid such as water. To understand the reason of this
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complexity, we have to study what is defined as the viscosity of a fluid. In fluid dynamics,
the viscosity of the fluid is a measure of its resistance to deformation by shear stress. We
can note that in a Newtonian fluid
τ = µ
(∇u+∇uT ) , (5.14)
the shear stress τ is proportional to the strain. According to Newton’s law of viscosity, this
momentum flow occurs across a velocity gradient, and the magnitude of the corresponding
momentum flux is determined by the viscosity µ, which is constant.
We can define a Newtonian fluid under constant temperature and pressure following the
description from Owen and Phillips [84]:
• The only stress generated in simple shear flow is the shear stress τ , the two normal
stresses being zero.
• The shear viscosity does not vary with shear rate.
• The viscosity is constant with respect to the time of shearing and the stress in the
liquid falls to zero immediately after the shearing is stopped.
• The viscosities measured in different types of deformation are always in a simple
proportion to one another.
Any liquid that deviates from the above behaviour is said to be non-Newtonian. Typical
examples of non-Newtonian fluids in nature are most of the body fluids, such as blood,
saliva, eye fluid, as well as many manufactured ones, such as toothpaste, paints, etc.
In particular, blood is a concentrated suspension of particles in plasma, which is mainly
made of water. There are three most important particles that constitute blood: red blood
cells (or erythrocytes), white cells (or leukocytes) and platelets (or thrombocytes). The first
ones, which are the most numerous, are the main responsible for the mechanical properties
of the blood [38]. In fact, their tendency to form (and then break down) 3D microstructures
at low shear rates and to align to the flow at high shear rates cause the blood’s shear thinning
behaviour, characterized by the monotonic decrease of the viscosity that tends to some limit
for very high shear-rates [39]. In the case of blood, the formed structures lead to significant
changes in its rheological properties and several models have been developed during the past
80 Chapter 5. Magnetic drug targeting
50 years in order to catch the complexity of this behaviour (some examples can be found in
[8, 21, 22, 50, 53, 99]). However, none of those models has been universally accepted.
In mathematical terms, we define a fluid as non-Newtonian if the extra-stress tensor
cannot be expressed as linear function of the components of the velocity gradient. The
nonlinear relation between the shear stress and shear rate can be written as
τ = η(γ˙)γ˙, (5.15)
where η(γ˙) is the viscosity and
γ˙ = (2eijeij)
1/2 =
[
1
2
(
∂ui
∂xj
+
∂uj
∂xi
)(
∂ui
∂xj
+
∂uj
∂xi
)]1/2
(5.16)
is the shear rate. For shear thinning fluids η is approximated by constant value as the shear
rate tends to zero. This indicates a Newtonian behaviour at very low shear rates. As the
shear rate is increased the viscosity varies in a non-linear manner until it reaches a second
plateaux value η∞, where the fluid behaviour can be considered Newtonian again.
The aim of this section is to compare different types of non-Newtonian fluids, focusing on
the accuracy of the approximation when varying η(γ˙). In particular, three famous models
for a non-Newtonian fluid are compared with the Newtonian case. These are:
1. Power–law model
The power–law model describes the viscosity by
ηp(γ˙) = m |γ˙|np−1 , (5.17)
where m is constant and γ˙ is the shear rate. If np < 1 the fluid is pseudoplastic or shear
thinning and if np > 1 it is dilatant or shear thickening. If np = 1 we obtain the Newtonian
viscosity.
2. Carreau model
The Carreau model describes the viscosity by
ηc(γ˙) = η∞ + (η0 − η∞)
[
1 + λ2γ˙2
](nc−1)/2
, (5.18)
where λ is a constant and η0 and η∞ are the limiting viscosities at low and high shear rates,
respectively. This model is very accurate to predict the shear thinning behaviour due to its
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ability to predict the two Newtonian plateaux values and the intermediate region observed
in experiments.
3. Ellis model
The Ellis model describes the viscosity in terms of shear stress
1
ηe
=
1
η0
(
1 +
∣∣∣ τ
τ1/2
∣∣∣α−1) , (5.19)
where η0 is the viscosity at zero shear and τ1/2 is the shear stress at which the viscosity is
η0/2. We note that this model cannot predict the viscosity in the second transition region
to the Newtonian plateaux value η∞. However, it is still very accurate for blood simulations
since very high level of shear strain are not reached.
In Figure 5.3 it is shown the behaviour of the models explained above in a logarithmic scale.
0
Figure 5.3: The viscosity/shear rate plot in logarithmic scale for the power law (red dotted-dashed
line), the Carreau (black solid line) and the Ellis models (green dashed line). The light grey dashed
lines represents the constant limit viscosities η0 and η∞.
Several theoretical studies to compare the accuracy of these models have been made
considering different types of fluids (see for example [52, 76, 100]). Typical values for the
blood case can be found in Table 5.2 and will be used in the simulations.
In the next section we compare the results obtained from the different models and
demonstrate the importance of choosing the right model for the blood flowing under the
influence of an external magnetic force.
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Quantity Symbol Value Units References
Newtonian viscosity µ 0.00345 Pa s [52]
Power-law viscosity m 0.0035 Pa s [76]
Power-law exponent np 0.3568 No. [76]
Carreau coefficient λ 3.313 No. [39]
Carreau viscosity at low shear rates η0 0.056 Pa s [39]
Carreau viscosity at high shear rates η∞ 0.00345 Pa s [39]
Carreau exponent nc 0.3568 No. [39]
Ellis viscosity at low shear rate η0 0.056 Pa s [76]
Ellis shear stress at η0/2 β 0.026 Pa [76]
Ellis exponent α 3.4 No. [76]
Table 5.2: Typical parameters for the blood flow equations for each model.
5.3.1 Governing equations and nondimensionalisation
In order to approximate the physical behaviour, we study the motion of the blood in a vessel
assuming that the vessel is a rectangular domain of length L and width 2R, where R L.
Lubrication theory can describe the flow when the diameter of the vessel is significantly
smaller than its length [83]. We will consider the lubrication model a good approximation
of the problem since all the vessels in the circulatory system comply this assumption, as we
can see from Table 5.1. As briefly introduced in Section 5.2, the flow is governed by the
Navier-Stokes equations (5.1)–(5.2). Equation (5.1) is the continuity equation and equation
(5.2) is the conservation of momentum. In our domain, the equations become:
∂u
∂x
+
∂v
∂y
= 0, (5.20)
∂u
∂t
+ u
∂u
∂x
+ v
∂u
∂y
= −1
ρ
∂p
∂x
+
1
ρ
[
∂τxx
∂x
+
∂τyx
∂y
]
, (5.21)
∂v
∂t
+ u
∂v
∂x
+ v
∂v
∂y
= −1
ρ
∂p
∂y
+
1
ρ
[
∂τxy
∂x
+
∂τyy
∂y
]
. (5.22)
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The velocity of the fluid is subject to the no-slip conditions at the vessel wall, so the fluid
has zero velocity at y = ±R. We compare three models where blood is consider as a
different non-Newtonian fluid. In order to understand the order of magnitude of the terms
in equations (5.20)–(5.22), we proceed with a standard non-dimensionalisation process for
the steady state flow. Consider the non-dimensional variables
x = Lxˆ, y = Ryˆ, u = Uuˆ, v = V vˆ, p = P pˆ, τ = T τˆ . (5.23)
Substituting (5.23) into (5.20) and dropping the hats, we have
U
L
∂uˆ
∂xˆ
+
V
R
∂vˆ
∂yˆ
= 0 (5.24)
and rearranging the terms we obtain
R
L
∂uˆ
∂xˆ
+
V
U
∂vˆ
∂yˆ
= 0. (5.25)
From (5.25) it is clear that we can balance the equation setting V = εU , where ε :=
R/L  1. This suggests that there are very small changes in the y direction. Hence, the
nondimensional continuity equation is
∂uˆ
∂xˆ
+
∂vˆ
∂yˆ
= 0. (5.26)
Substituting (5.23) into (5.21), we have
U2
L
uˆ
∂uˆ
∂xˆ
+
V U
R
vˆ
∂uˆ
∂yˆ
= − P
ρL
∂pˆ
∂xˆ
+
T
ρ
[
1
L
∂τˆxˆxˆ
∂xˆ
+
1
R
∂τˆyˆxˆ
∂yˆ
]
. (5.27)
Considering V = εU and choosing P = LT /R, we can write
εU2
[
uˆ
∂uˆ
∂xˆ
+ vˆ
∂uˆ
∂yˆ
]
=
T
ρ
[
−∂pˆ
∂xˆ
+ ε
∂τˆxˆxˆ
∂xˆ
+
∂τˆyˆxˆ
∂yˆ
]
(5.28)
and making the the further assumption
εU2ρ
T  1, (5.29)
at leading order we can neglect most of the terms obtaining
∂pˆ
∂xˆ
=
∂τˆyxˆ
∂yˆ
. (5.30)
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Notice that equation (5.29) is equivalent to assume that the reduced Reynolds number is
small for the classical lubrication theory [83]. Following the same idea we can neglect almost
all the terms of equation (5.22), since we have
ε3U2
[
uˆ
∂vˆ
∂xˆ
+ vˆ
∂vˆ
∂yˆ
]
=
T
ρ
[
−∂pˆ
∂yˆ
+ ε2
∂τˆxˆyˆ
∂xˆ
+ ε
∂τˆyˆyˆ
∂yˆ
]
. (5.31)
Therefore, dropping the hats, the non-dimensional system (5.20)–(5.22) at the leading order
can be written as
∂u
∂x
+
∂v
∂y
= 0 (5.32)
∂p
∂x
=
∂τyx
∂y
(5.33)
∂p
∂y
= 0 (5.34)
which is a much simpler problem.
The final non-dimensional scales are V = εU and P = T /ε, where T depends on the
fluid chosen. That is, equations (5.20)–(5.22) will differ in the only term in the shear tensor
that appears in the equations, which is τyx. In this case we assume the shear rate given by
definition as the gradient of the velocity as in equation (5.16) and we are considering that
the fluid fluctuations in the x-direction are negligible due to the particular geometry, which
means γ˙ ≈ |uy|.
In the simple case of a Newtonian fluid, the shear stress (5.14) can be written as
τyx = µ
∣∣∣∣∂u∂y
∣∣∣∣ , (5.35)
where µ is constant.
For the power law model (5.17), we have
τyx = m
∣∣∣∣∂u∂y
∣∣∣∣np , (5.36)
where m is a constant.
For the Carreau model (5.18), then
τyx = η∞ + (η0 − η∞)
(
1 + λ2
∣∣∣∣∂u∂y
∣∣∣∣2
)nc−1
2
∣∣∣∣∂u∂y
∣∣∣∣ , (5.37)
where η0 is the initial shear rate and η∞ the equilibrium shear rate.
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For the Ellis model (5.19), we have an implicit equation relating the viscosity with the
stress-tensor
1
ηe
=
1
η0
(
1 +
∣∣∣τyx
β
∣∣∣α−1) (5.38)
where η0 is the constant viscosity at zero shear and β is the value of τyx when η = η0/2. In
this case, we will use the value fitted in [76].
Therefore, we will consider
T =

µUR if we choose τ as in (5.35),
m
(
U
R
)np if we choose τ as in (5.36),
η0
(
U
R
)nc if we choose τ as in (5.37),
η0
(
U
R
)α if we choose τ as in (5.38).
(5.39)
5.3.2 Comparison of the models
In order to choose the most accurate non-Newtonian law for our physical problem we start
from the simplest model for a Newtonian fluid. This was used in several previous works in
order to simplify the calculation. We then compare the result with more complex and more
accurate models with a non-Newtonian fluid. In all cases we consider a Hagen-Poiseuille
flow in a channel, which is driven by a pressure gradient ∆p/L. Since the movement of the
fluid in the y-direction is quite small compared with the x-direction, we will approximate
our solution by a uni-directional flow with ux = 0. Moreover, the flow has a constant
volumetric flow rate Q.
The Newtonian fluid model
The solution for the simplest model that we can use is given by solving equations (5.32)–
(5.34) where the shear-stress is described by (5.35). Since equation (5.34) implies that the
pressure does not vary with y, integrating (5.33) twice with respect to y, we can find
u(y) =
1
2µ
(
−∂p
∂x
)(
R2 − y2) . (5.40)
Therefore, we can consider the flux
Q =
∫ R
−R
u(y)dy =
(
−∂p
∂x
)
2R3
3µ
. (5.41)
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and, since mass is conserved, Q is constant. Hence, we can write
∂p
∂x
= −3µQ
2R3
, (5.42)
and substitute this expression in (5.40), obtaining the velocity as a function of the flux
u(y) =
1
2µ
(
3µQ
2R3
)(
R2 − y2) = 3Q
4R3
(
R2 − y2) . (5.43)
The power law model
The steady state equations of the motion of a non-Newtonian flow, considering the power-
law form for the viscosity, equation (5.33) is now replaced with
∂p
∂x
=
∂
∂y
(
m
∣∣∣∣∂u∂y
∣∣∣∣n) . (5.44)
Considering uy|y=0 = 0 and the no-slip condition at y = ±R, we can integrate (5.44) twice
with respect to y and obtain the solution for the velocity
u(y) =
(
− 1
m
∂p
∂x
) 1
n
(
n
n+ 1
)(
R
n+1
n − |y|n+1n
)
. (5.45)
Similarly to the Newtonian flow, we can find that Q is given by
Q =
∫ R
−R
udy =
(
− 1
m
∂p
∂x
) 1
n
(
n
2n+ 1
)
R
2n+1
n . (5.46)
Therefore, we can write
(
− 1
m
∂p
∂x
) 1
n
=
(
2n+ 1
n
)
Q
R
2n+1
n
, (5.47)
and this gives the velocity as function of the flux
u(y) =
Q
R
2n+1
n
(
2n+ 1
2n+ 2
)(
R
n+1
n − |y|n+1n
)
. (5.48)
One of the main advantages of this model is that it is easy to obtain the analytical
solution to the governing equation. However, there are two major disadvantages with
make it appropriate for the blood modelling: the viscosity is unbounded as γ˙ → 0 and the
limit as γ˙ →∞ is zero.
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The Carreau model
Choosing the Carreau model for the viscosity (5.37), the equations of the flow are reduced
to (5.32) and (5.34) coupled with
∂p
∂x
=
∂
∂y
η∞ + (η0 − η∞)(1 + λ2∣∣∣∣∂u∂y
∣∣∣∣2
)n−1
2
∣∣∣∣∂u∂y
∣∣∣∣
 . (5.49)
This expression cannot be integrated analytically and we will have to solve it numerically
via the in-built bvp5c function in Matlab.
The Ellis model
When choosing the Ellis model (5.38), the equations of the flow are (5.32) and (5.34) coupled
with
∂u
∂y
=
(
∂p
∂x
1
η0
)[
1 +
∣∣∣∣(∂p∂x
)
y
β
∣∣∣∣α−1
]
y. (5.50)
Following [76], assuming uy(0) = 0, we can write an explicit expression for the velocity of
the fluid
u(y) =
1
η0
∂p
∂x
[
R2 − |y|2
2
+
(
1
β
∂p
∂x
)α−1 Rα+1 − |y|α+1
α+ 1
]
, (5.51)
where η0 is the viscosity at low shear rate. The flux is then calculated by
Q =
1
η0
∂p
∂x
[
R3
3
+
(
1
β
∂p
∂x
)α−1 Rα+2
α+ 2
]
, (5.52)
which gives only one real solution for the pressure gradient.
5.3.3 Velocity and viscosity
In order to compare the four models and their velocity field we have to pay attention to
the choice of the parameter values. As already explained, the viscosity strongly depends
on temperature, so for the whole chapter we use parameters consistent with temperature
equal to 37°C, which is a reasonable choice for the human body.
The geometry parameters are common for all the models and represents an artery with
length and width as in Table 5.1. The flow entering in a small artery can be approximated
by Q ≈ 1.9 × 10−6 m3/s [39]. Therefore, the pressure gradient driven the flow is obtained
from either (5.42), (5.47) or (5.52). The rest of parameters used for the simulations of
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the velocity and of the viscosity in the vessel are listed in Table 5.2. The parameters for
the Newtonian, power–law and Carreau models are widely used in the literature (see for
example [22, 38, 52]), while the parameters for Ellis model are taken from [76].
The velocity profiles and the corresponding viscosity profiles for blood obtained from the
four different models of Section 5.3.2 are compared in Figures 5.4(a) and 5.4(b), respectively.
We can observe that, even if a good agreement for the velocity behaviours is observed, the
relative viscosities can differ significantly. For the purpose of this project, the value for the
viscosity of the blood will be crucial in the calculation of the velocity of the particles which
will determinate whether the drug is able to reach the wall of the vessel or not. Figure
5.4(b) shows clearly that, for example, the viscosity of the power-law model, represented
by the red dashed-dotted line, tends to infinity as y → 0 while the other viscosities have
a very different value there. Both Ellis and Carreau models give similar approximations
for the blood flow given their capacity to catch its shear thinning behaviour. The Carreau
model is generally preferred due to its ability to predict both Newtonian plateaux but, in
the cases when high shear rates are not reached and considering this particular geometry,
the Ellis model can be treated analytically, which is a powerful tool.
(a) (b)
Figure 5.4: Comparison of (a) velocity and (b) viscosity profiles of Newtonian (represented by the
letter N and the blue dotted line), power-law (represented by PL and the red dashed-dotted line),
Carreau (represented by the letter C and the black solid line) and Ellis model (represented by the
letter E and the green dashed line).
5.4. Concentration of nanoparticles 89
5.4 Concentration of nanoparticles in a non-Newtonian flow
subject to an external magnetic field
The behaviour of the concentration of magnetic nanoparticles in the bloodstream is obtained
following the continuum model developed by Grief and Richardson [45]. The governing
equation describing the motion of magnetic particles in the blood stream is an advection-
diffusion equation for the particle concentration c(x, y, t):
∂c
∂t
+∇ · [(uF + up)c] =∇ · (D∇c) (5.53)
where uF is the fluid velocity given by the solution of (5.32)–(5.34), up is the particle velocity
and D is the diffusion coefficient. We can decouple equation (5.53) from the equations for
the flow because we assume that we are in a dilute limit where the particles concentration
does not affect the flow.
The diffusive character of the equation is given by the contributions of the Brownian
motion, which is the random motion of particles under thermal fluctuations, and the
shear-induced diffusion, which is due to the fact that the red blood cells suspended in
plasma collide with each other causing random motion with a diffusive character. As
recently demonstrated by Liu and coworkers [64, 65] via a lattice-Boltzmann based
multiscale simulation, the diffusion due to the Brownian motion in the case of
nanoparticles transport in a small vessel can be important and, in some cases, even the
predominant diffusion process. Using the Stokes-Einstein equation for the diffusion of
spherical particles through a shear thinning fluid [39], we can write the Brownian diffusion
coefficient as
DBr =
kBT
6pi η(γ˙) a
, (5.54)
where kB is Boltzmann constant, T the absolute temperature, η(γ˙) is the viscosity of the
blood (which depends on the model chosen) and a the particle radius. On the other hand,
the shear-induced diffusion contribution can be approximated by
Dsh = Ksh (rRBC)
2 γ˙, (5.55)
where Ksh is a dimensionless coefficient that depends on the blood cell concentrations, rRBC
is the red blood cell radius and γ˙ is the fluid shear rate defined in (5.16). The coefficient
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Ksh is difficult to measure but the value used in Table 5.3 is considered representative in
literature [45]. Hence, the total diffusion will be Dtot = DBr +Dsh, obtaining:
Jdiff = −Dtot∇c = −
(
kBT
6pi η(γ˙) a
+Ksh (rRBC)
2 γ˙
)
∇c. (5.56)
The particle velocity is found by balancing hydrodynamic and magnetic forces. We can use
the definition of the Stokes drag, which is the force of viscosity on a spherical particle of
radius a moving through a viscous fluid, which is
FSt = 6pia η(γ˙)up, (5.57)
where η(γ˙) depends on the model chosen for the blood. The particles reaches its equilibrium
velocity when FSt balances the magnetic force Fmag and this leads us to the expression
up =
Fmag
6pia η(γ˙)
. (5.58)
Hence, finally the governing equation can be written as
∂c
∂t
+∇ · (utotc) =∇ · (Dtot∇c) , (5.59)
where utot = uF + up.
As introduced in Section 5.2.1, we can consider up = (0, vp(y)) for a magnet situated at
a long distance compared to the vessel width. Considering that the particles can flow out
of the vessel through the walls with a certain vascular permeability κ, we will impose Robin
boundary conditions at the top and the bottom of the channel of the form(
vpc−Dtot ∂c
∂y
) ∣∣∣
y=±R
= κ c|y=±R. (5.60)
We also need to specify the inlet and the outlet conditions. Assuming that the flux entering
in the channel is constant and equal to the inlet concentration cin for a certain interval of
time [0, Tinj], we set
c(x, y, t)|x=0 =

cin if 0 ≤ t ≤ Tinj,
0 otherwise,
(5.61)
and (
uF c−Dtot ∂c
∂x
) ∣∣∣
x=L
= 0, (5.62)
assuming that at the end of the channel we are sufficiently far from the magnet that its
effect is almost zero. The initial value problem is well-posed with the initial condition
c(x, y, 0) = 0.
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5.4.1 Nondimensionalisation of the advection-diffusion equation
As already noted in Section 5.3.1, due to the particular geometry chosen, in the y-direction
the movement of the fluid is quite small compared to the horizontal direction. In order
to simplify our problem we then assume in the analysis of the particle concentration that
the flow of the blood is horizontal and we can write uF = (uF (y), 0). Moreover, since
up = (0, vp(y)), the governing equation (5.59) becomes
∂c
∂t
+ uF
∂c
∂x
+
∂(vpc)
∂y
= Dtot
∂2c
∂x2
+
∂
∂y
(
Dtot
∂c
∂y
)
, (5.63)
since Dtot = Dtot(y). In this case, we will study the unsteady advection-diffusion equation
for the concentration, which will change more quickly in time with respect to the fluid.
Substituting the non-dimensional variables detailed in (5.23) and
t = T tˆ, c = c0 cˆ, uF = UuˆF , vp = Wvˆp, Dtot = DDˆtot, (5.64)
into (5.63) we obtain
c0
T
∂cˆ
∂tˆ
+
Uc0
L
uˆF
∂cˆ
∂xˆ
+
Wc0
R
∂(vˆpcˆ)
∂yˆ
=
Dc0
L2
(
Dˆtot
∂2cˆ
∂xˆ2
)
+
Dc0
R2
∂
∂yˆ
(
Dˆtot
∂cˆ
∂yˆ
)
. (5.65)
Rearranging the terms, choosing T = L/U in order to balance the time derivative with the
advection term, we can write
∂cˆ
∂tˆ
+ uˆF
∂cˆ
∂xˆ
+
δ
ε
∂(vˆpcˆ)
∂yˆ
=
1
εPe
[
ε2
(
Dˆtot
∂2cˆ
∂xˆ2
)
+
∂
∂yˆ
(
Dˆtot
∂cˆ
∂yˆ
)]
, (5.66)
where δ = W/U and Pe = D/(RU) is the Péclet number and depends on the model chosen
since the Brownian diffusion is a function of η(γ˙). According to the values in Table 5.3,
O(εPe)−1 ≈ [10−6, 10−5] depending on the fluid chosen, while ε = O(10−2), hence both
terms of the right side of the equation are quite small. Therefore, as commonly happens,
the advective terms are dominant and when analysing them, it is important to understand
the order of magnitude of the fraction δ/ε. In particular we can distinguish three regions
in the domain (symmetric with respect to the center of the vessel): a central region where
O(δ) < O(ε), which is the broadest one where the drag force is winning over the magnetic
force; a second region where O(δ) ≈ O(ε) where both advective terms are order one and
balance each other; finally, very near to the wall of the vessel, we can find a narrow boundary
layer where O(δ) > O(ε) and the vertical motion is the dominant in the equation.
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5.4.2 Analytical solutions
In order to have an idea about the behaviour of the concentration, it can help to find
analytical solutions for some simpler problem. Firstly, since the diffusion contribution is
quite small, we will look for the solution of the associated advection equation with constant
coefficients. Secondly, constant diffusion terms are added and the equation is solved for a
particular initial condition.
Advection equation
Since in all of the realistic cases the diffusion coefficient is quite small, the advection terms
are going to dominate. In order to have an idea of the behaviour of the concentration, we
want to find the analytical solution of the advection equation in an unbounded domain with
constant coefficients
∂c
∂t
+ u0
∂c
∂x
+ v0
∂c
∂y
= 0, (5.67)
with a certain initial condition c(x, y, 0) = c0(x, y). It is well-known that in the case of
constant transport, the method of characteristics is a widely used technique which leads to
write the solution in terms of the initial condition, in the form
c(x, y, t) = c0(x− u0t, y − v0t). (5.68)
If we choose the initial condition in order to simulate a point injection at (x0, y0) which
corresponds to a function of the form c0(x, y) = Mδ(y− y0)δ(x−x0), where M is constant.
The solution is then easily found as
c(x, y, t) = Mδ(x− x0 − u0t)δ(y − y0 − v0t). (5.69)
Taking into account that the goal of this analysis is to plot the analytical solution in order
to have an initial idea of the original system, we consider the smoother function
c0(x, y) = exp
[
−(x− x0)
2
r0x
− (y − y0)
2
r0y
]
, (5.70)
which gives
c(x, y, t) = exp
[
−(x− x0 − u0t)
2
r0x
− (y − y0 − v0t)
2
r0y
]
. (5.71)
5.4. Concentration of nanoparticles 93
Constant advection–diffusion equation
Let us consider now the full advection-diffusion equation in an unbounded domain with
constant coefficients
∂c
∂t
+ u0
∂c
∂x
+ v0
∂c
∂y
= Dx
∂2c
∂x2
+Dy
∂2c
∂y2
. (5.72)
where c(x, y, 0) = c0(x, y) represents a point injection at some (x0, y0), i.e. c0(x, y) =
Mδ(y− y0)δ(x− x0), where M is constant. Let us take (x0, y0) = (0, 0) and M = 1. Then,
as suggested in [123], we will look for a solution of the form
c(x, y, t) = g1(x, t)g2(y, t). (5.73)
Hence, g1 satisfies
∂g1
∂t
+ u0
∂g1
∂x
= Dx
∂2g1
∂x2
, (5.74)
with g1(x, 0) = δ(x). Applying the change of variables z = x − u0t we obtain the classical
diffusion equation
∂g1
∂t
= Dx
∂2g1
∂z2
. (5.75)
In the same way explained in Chapter 2, we can proceed with another coordinate
transformation via the similarity variables η = Atαz and g1(z, t) = Atαf(η). The
transformed derivatives become
g1t = (At
α)tf + fηηt = αAt
α−1(f + ηfη), (5.76)
g1z = At
αfηηz = A
2t2αfη, (5.77)
g1zz = (g1z)z = A
2t2α(fη)ηηz = A
3t3αfηη, (5.78)
and putting these expressions into (5.75) we have
αAtα−1(f + ηfη) = DA3t3αfηη, (5.79)
which when simplified gives
α(f + ηfη) = DA
2t2α+1fηη. (5.80)
In order to remove the time dependence, we set α = −1/2 and A = 1/√2D, obtaining
fηη + ηfη + f = 0. (5.81)
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It easy to notice that ηfη + f = (ηf)η, hence we can rewrite (5.81) as
∂
∂η
(fη + ηf) = 0, (5.82)
which implies that fη+ηf has to be constant. It can be shown that without loss of generality,
we can assume fη + ηf = 0, and integrate∫
∂f
f
= −
∫
η∂η, (5.83)
which finally gives the solution for the function f as
log(f) = −η
2
2
+ C1 ⇒ f = C2e
η2
2 . (5.84)
It can be shown that, for mass conservation motivations, C2 = 1/(2
√
pi) and recalling the
initial change of variables
η =
z√
2Dxt
, g1(z, t) =
f(η)√
Dxt
(5.85)
we can write the solution
g1(z, t) =
1
2
√
2piDxt
exp
(
− z
2
4Dxt
)
. (5.86)
Finally, we can return to the original coordinates, obtaining the solution for the advection
diffusion equation (5.74)
g1(x, t) =
1
2
√
2piDxt
exp
(
−(x− ut)
2
4Dxt
)
. (5.87)
This result is analogous for the function g2(y, t) and the solution can be generalized through
(5.73) for the two dimensional problem as
c(x, y, t) =
1
4pit
√
DxDy
exp
[
−(x− u0t)
2
4Dxt
− (y − v0t)
2
4Dyt
]
. (5.88)
Analytical solutions for the bounded problem in two dimensions would be more accurate but
also more complicated. For the purpose of this project they are not necessary but they can
be found in [30, 70]. The analytical solutions give us an idea about how the concentration
of particles will behave in the original problem and, especially, will be useful to understand
the behaviour for small times. This information will be used to avoid difficulties for the
initial condition in the numerical scheme.
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5.5 Numerical approximations
5.5.1 Small time analysis
A well-known difficulty when solving several problems numerically is to adapt the rapidly
changes in the variables that a continuum solution can include to the numerical code. In
this case, at the beginning of the process, there are no drugs flowing in the vessel, that is
c(x, y, 0) = 0, but as soon as t > 0 we inject a concentration of particles c(x0, y0, t) = cin. To
overcome this issue, a small time analysis on the related equation with constant coefficients
is performed. Let us consider a constant diffusion coefficient D¯tot, where the bar represents
the average value of the sum of the Brownian and shear-induced diffusive contributions
divided by Pe. Since the interest is to understand the solution for small times and close to
the inlet, let t = εt¯ and x = εbx¯, where ε 1 and b is going to be determined.
Introducing these new variables in equation (5.66), we have
1
ε
∂c
∂t¯
+
1
εb
u¯F
∂c
∂x¯
+
δ
ε
v¯p
∂c
∂y
=
D¯tot
ε
(
ε2
ε2b
∂c2
∂x¯2
+
∂c2
∂y2
)
, (5.89)
which can be rewritten as
∂c
∂t¯
+ ε1−bu¯F
∂c
∂x¯
+ δv¯p
∂c
∂y
= D¯tot
(
ε2−2b
∂c2
∂x¯2
+
∂c2
∂y2
)
. (5.90)
In order to remove the dependence on ε, we impose b = 1, i.e. x = εx¯ is scaled exactly like
the time variable. With the new scale, the leading order of equation (5.90) will be
∂c
∂t¯
+ u¯F
∂c
∂x¯
+ δv¯p
∂c
∂y
= D¯tot
(
∂c2
∂x¯2
+
∂c2
∂y2
)
. (5.91)
In an unbounded domain, as explained in Section 5.4.2, the solution of (5.91) is
c(x¯, y, t¯) =
1
4pit¯D¯tot
exp
[
−(x¯− u¯t¯)
2
4D¯tott¯
− (y − δv¯pt¯)
2
4D¯tott¯
]
, (5.92)
and since for small times the particles are far from the vessel walls, we can use this
information for the initial value of the system and avoid numerical problems due to the
initial jump of the continuum.
5.5.2 Parameter estimation
Several parameters are playing a crucial role in this dynamic. However, in order to show the
importance of the viscosity of the blood, the focus of the simulations will be to understand
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the behaviour of the particle concentration comparing the Newtonian and non-Newtonian
approximations of the flow. In this section, we will justify and estimate the others key
parameters, such as the dimensions of the vessel, the strength of the magnetic field and the
permeability of the vessel’s wall.
As many authors observed (see for example [31, 68, 95]), very different scenarios can
arise when looking at different types of vessel. In fact, the technique of magnetic drug
targeting is hard to conduct in the main vessels where particles must overcome a strong
flow and long distances, and on the other hand the smaller vessels have the complication
derived from the possible agglomeration of particles occluding the stream. Moreover, in the
case of capillaries, red blood cells are of the same dimension of the width of the vessel itself
and their elastic properties should be taken into account in the model. In arteries, even if
normally considered large vessels where the effect of RBCs aggregation is reduced, we can
observe the non-Newtonian behaviour due to the presence of spots of low shear rates, such
as bends and bifurcation junctions, or in the case of pathological conditions. For this reason
we choose to focus our study on them.
As highlighted in Section 5.4.1, if the magnetic force is too weak to overcome the strength
of the fluid drag, particles will be “washed away" with the blood along the vessel. On the
other hand, a too strong magnetic field cannot be applied in order to avoid damage to
human body. Hence, a balance that also takes into account the distance from the particles
to the wall needs to be found. In addition to the viscosity of the blood, the strength of
the magnetic field is a key parameter in the calculation of the velocity of the particles.
It is noted that the application of the magnetic field is dictated by international rules, in
order to minimise side effect damage. The World Health Organization states that a person
moving within a field above 2T can experience adverse effects such as nausea and vertigo
but static magnetic fields can cause acute effects only likely within fields in excess of 8T
(for example, MRI scanners produces one of about 3T). International guidelines for public
exposure to magnetic fields set an upper limit of 40mT which is around 1000 times stronger
than the Earth’s magnetic field. However, in the case of magnetic fields applied in drug
targeting therapies, between 0.1T–1.5T in animal trials and 0.2T–0.8T in human clinical
trials were used [28]. Most of the simulations cited in this thesis follow this range and all
the approximations explained in Section 5.2.1 lead to similar values for the magnetic force
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acting on particles. In both [45, 94] particles with a magnetite volume fraction Υ = 0.1,
i.e. that the particles contain the 10% magnetite by volume, are considered. They set
the mass magnetization Msat = 50 A m2 kg−1 and density ρ = 5 × 103 kg m−3, under
a magnetic field gradient BG = 10 T m−1. Taking the case of the artery, using equation
(5.13), they obtain a magnetic force F0 ∈ [10−15, 10−12] N, depending on the size of the
particle, which is in the range of µm. In [82], iron oxide nanoparticles are subjected to a
magnetic force of about 1.9× 10−13 N, whose value is obtained using equation (5.9) where
a = 250 nm, µ0 = 4pi × 10−7 N A−2, χ = 20 and the the magnetic spatial gradient of the
order of 107 A/m2. The experiment is produced by a permanent magnet with B = 0.5T
which produces a magnetic field intensity H = 3.7 × 105 A/m. It is important to notice
that while smaller particles have as advantage to avoid agglomeration once magnetic field
is removed, we will need a stronger magnetic field gradient in order to compete with the
drag force, since magnetic force scales with volume. In Section 5.5, simulations show how
particles are affected by a magnetic force of the order O(10−13) N. The fact that a stronger
magnetic field is needed, with respect to the microscale choices, it is also explained by the
size of the particles. In fact, magnetic forces scale with volume, in contrast to the drag
force, therefore at the nanoscale a stronger field is needed to provide the same result.
Another key value is the permeability of the vessel. In fact, in the blood circulatory
system certain types of vessels have stronger walls, reducing the possibility of particles to
get out of the blood stream and into the surrounding tissue. The permeability coefficient κ
represents the capacity of the vessel to let the concentration of particles pass through the
wall. As theoretically predicted from Richardson et al. [94] via the matched asymptotic
technique, the parameter κ plays an important role in the determination of the position of
the particles deposited onto the vessel wall. In fact, their outer solution shows how small
values of the permeability are responsible for the formation of a boundary layer region
in the immediate vicinity of the wall where the advective flux balances the diffusive flux
and the thickness of the vessel wall prevents particles from flowing out. In this project, a
representative value for κ = O(10−4) is chosen in order to represent a type of wall where
particles are able to pass through but a small boundary layer is observed.
In Table 5.3 all the parameters needed for the advection-diffusion equation are listed.
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Quantity Symbol Value Units References
Blood cell radius rRBC 4.2× 10−6 m [45]
Coeff. blood cell conc. Ksh 5× 10−2 No. [45]
Inlet concentration cin 1 mol m−3 [82]
Particle radius a 15× 10−9 m [45]
Boltzmann constant kB 1.38× 10−23 m2 kg s−2 K−1 [39]
Temperature T 310.15 K [39]
Table 5.3: Dimensional parameters for the particles concentration equation.
5.5.3 Finite difference scheme
In order to simulate the behaviour of the concentration of particles, we will define a finite
difference scheme for the advection–diffusion equation (5.63), subject to the boundary
conditions (5.60)–(5.62) and initial condition c(x, y, 0) = 0. Advection terms will dominate
in the equation but the diffusive contribution becomes important near the wall of the
vessel, where the fluid have near zero velocity. Diffusion terms also help to stabilize the
numerical scheme. The finite difference scheme includes the approximation by forward
Euler in time, first order upwind for the advection terms and central differences for the
second derivatives. The velocity of the fluid uF , its derivatives and the velocity of the
particles vp are known values at each time step.
Let us consider a grid of length L and width 2R composed by nx×ny nodes. The spatial
steps will be ∆x = L/(nx − 1) and ∆y = 2R/(ny − 1), and ∆t is chosen in order to satisfy
the stability condition of the scheme. We will use the intuitive notation
cni,j := c(xi, yj , t
n), uFj := uF (yj), vpj := vp(yj), DTj := Dtot(yj). (5.93)
The choice of the direction of the upwind step is made considering that the solution of the
velocity of the fluid is always non negative and the direction of the velocity of the particle
is always negative (since we have positioned the magnet below the vein). Then, equation
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(5.63) can be approximated as
cn+1i,j − cni,j
∆t
+ uFj
(
cni,j − cni−1,j
∆x
)
+
(
vpj+1c
n
i,j+1 − vpjcni,j
∆y
)
=
+DTj
(
cni+1,j − 2cni,j + cni−1,j
∆x2
)
+DT
j+12
(
cni,j+1 − cni,j
∆y2
)
−DT
j− 12
(
cni,j − cni,j−1
∆y2
)
,
(5.94)
where DT
j± 12
are evaluated by the arithmetic mean. We also need to specify the inflow
boundary conditions at x = 0 and y = ±R. On the left border, where the concentration of
drugs is injected for a limited interval of time, we have that
cn1,j =

cin for 0 ≤ tn ≤ Tinj,
0 otherwise,
(5.95)
for j = 1, . . . , ny, since we stop injecting nanoparticles at Tinj.
On the wall of the vessel, that is the upper and the lower side of the rectangle, we
approximated conditions (5.60), by which particles can pass through the vein with a constant
permeability coefficient equal to κ, through the three-point backward difference formula
vpny c
n+1
i,ny
−DTny
(
3cn+1i,ny − 4cn+1i,ny−1 + cn+1i,ny−2
2∆y
)
= −κcn+1i,ny (5.96)
and the three-point forward difference formula
vp1 c
n+1
i,1 −DT1
(
−cn+1i,3 + 4cn+1i,2 − 3cn+1i,1
2∆y
)
= κcn+1i,1 (5.97)
for i = 1, . . . , nx.
The right border is approximated again through the three-point forward difference
formula
uFjc
n+1
nx,j
−DTj
(
−cn+1nx−2,j + 4cn+1nx−1,j − 3cn+1nx,j
2∆x
)
= 0 (5.98)
for j = 1, . . . , ny.
5.5.4 Results
In this section we present the results obtained by comparing the effects that the different
choices of the fluid models have on the motion of the particles in the bloodstream.
The geometry chosen represents a simplification of a small artery having width and
length like in Table 5.1. The velocity of the blood and the relative viscosity will be
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approximated by the solutions (5.40) and (5.51) and by the numerical approximation of
the solution of (5.49) for the Newtonian, the Ellis and the Carreau models, respectively.
The power-law model is not presented, since it has been shown that its viscosity
approximation does not fit the blood behaviour. The velocity of the particles vp will be
calculated via equation (5.58) considering a constant magnetic force F0 and a viscosity
η(γ˙) given by the constant value µ in the case of a Newtonian fluid, or calculated via
(5.19) and (5.18) for the Ellis and the Carreau models. A five seconds long initial injection
at x = 0 is applied (that is Tinj = 5s). The plots for the particles concentration are
obtained implementing the numerical scheme detailed in Section 5.5.3 in Matlab where
the parameters listed in Tables 5.2 and 5.3 are used. The aim of all the simulations is to
understand how the approximation can vary according to the model chosen for the blood.
Moreover, special attention will be paid to the strength of the magnetic force needed in
order to target particles to the disease area.
Figure 5.5 shows the behaviour of the concentration of nanoparticles in the vessel where
the Newtonian approximation for blood is considered. The first plot represents the velocity
field, which is given by the contribution of the drag of the fluid and the magnetic force acting
on the system. Since the velocity of the particles depends on the viscosity of the fluid and
the Newtonian approximation implies a constant value for η(γ˙), the changes in the velocity
field are only due to the parabolic profile of uF and, therefore, only in the x-direction. The
other images show the snapshots of the concentration of particles at six fixed times under
the influence of a constant magnetic force F0 = 1 × 10−13 N. We can observe how all the
particles entering the bloodstream from the left border are driven to the lower wall of the
vessel and captured into the tissue halfway through the channel in about 30s.
In Figures 5.6 and 5.7 the equivalent plots to those of Figure 5.5 are shown but now using
the Carreau and the Ellis models, respectively, instead of the Newtonian one. Both models
give a very similar approximation for the behaviour of the concentration of particles, which
is a direct consequence of what was demonstrated in Section 5.3.2. However, we can clearly
see that the same magnetic force used in the previous simulation is now unable to drive the
particles towards the same region. In fact, even if a slight movement in the y-direction can
be observed and the particles very near to the vessel’s wall are able to get into the tissue,
most of the particles are “washed away" by the drag force. This change can be observed
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in the first image of both figures, where the velocity field highlights the differences with
the previous case. This clearly shows that using a Newtonian fluid model can result in the
wrong conclusion that a magnetic force of that strength is able to target a specific region.
As shown in Figures 5.8 and 5.9, we will need a magnetic force eight times greater than
in the Newtonian case in order to be able to attract particles to the lower wall of the vessel
when considering the Carreau and the Ellis model, respectively. Looking at the first image
of both figures, the velocity field shows clearly how the different profiles for the viscosity
strongly changes the behaviour of the concentration. Furthermore, we can observe how the
particles near the vessel wall experience a much smaller drag force with respect to those at
the center of the vessel and, therefore, will react strongly to the magnetic force and deviate
from the typical parabolic behaviour of the fluid. Moreover, the diffusive contribution plays
an important role in this region and influence the motion of the particles at this scale. In
the six snapshots of the concentration for six different times we can observe how particles
driven by the balance of all the forces acting on this system are attracted by the external
magnetic field to the wall of the vessel and pass through it in about 40s. In these plots,
especially at t = 6s and t = 15s, we can also observe a thin boundary layer where particles
accumulate in the immediate proximity to the wall, as theoretically predicted in [94].
All the simulations confirm the importance of choosing the appropriate fluid model,
specifically one where the viscosity follows the shear-thinning behaviour of the blood in
order to correctly predict whether a specific magnetic field is able to attract particles to
the desired area and in which amount of time. Moreover, even if Brownian diffusion seems
negligible for the majority of the domain, it is important near the wall of the vessel and can
even be the predominant diffusive contribution for small particles.
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Figure 5.5: Snapshots of the concentration of particles in an artery at six different times (t = 0s,
t = 4s, t = 6s, t = 10s, t = 15s, t = 30s), choosing the Newtonian model for the blood flow and with
a constant magnetic force equal to F0 = 1× 10−13 N. The first image represents the velocity field.
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Figure 5.6: Motion of magnetic nanoparticles in an artery at six different times (t = 0s, t = 4s,
t = 6s, t = 10s, t = 15s, t = 30s and t = 40s), choosing the Carreau model for the blood flow
and with a constant magnetic force acting on particles equal to F0 = 8× 10−13 N. The first image
represents the velocity field.
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Figure 5.7: Snapshots of the concentration of particles in an artery at six different times (t = 0s,
t = 4s, t = 6s, t = 10s, t = 15s, t = 30s), choosing the Ellis model for the blood flow and with a
constant magnetic force equal to F0 = 1× 10−13 N. The first image represents the velocity field.
5.5. Numerical approximations 105
t = 0 s
0
0.2
0.4
0.6
0.8
1
t = 2 s
0
0.2
0.4
0.6
0.8
1
t = 6 s
0
0.2
0.4
0.6
0.8
1
t = 15 s
0
0.2
0.4
0.6
0.8
1
t = 30 s
0
0.2
0.4
0.6
0.8
1
t = 40 s
0
0.2
0.4
0.6
0.8
1
Figure 5.8: Motion of magnetic nanoparticles in an artery at six different times (t = 0s, t = 4s,
t = 6s, t = 15s, t = 30s and t = 40s), choosing the Carreau model for the blood flow and with a
constant magnetic force acting on particles equal to F0 = 8 × 10−13 N. The first image represents
the velocity field.
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Figure 5.9: Motion of magnetic nanoparticles in an artery at six different times (t = 0s, t = 4s,
t = 6s, t = 15s, t = 30s and t = 40s), choosing the Ellis model for the blood flow and with a
constant magnetic force acting on particles equal to F0 = 8 × 10−13 N. The first image represents
the velocity field.
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5.6 Conclusion
We have formulated a model for the motion of magnetic nanoparticles in a vessel subject
to an external magnetic field in order to optimize the technique of magnetic drug targeting.
The model consists of a system of nonlinear partial differential equations formed by the
Navier-Stokes equations for the flow of blood coupled with an advection-diffusion equation
for the concentration of nanoparticles. Choosing a 2D vessel, the equations are simplified
and the system is solved via analytical and numerical techniques.
The aim of this project has been to account for all the forces acting in the physical
process, combined with realistic choices for parameters. It has been shown that, in order to
correctly simulate the delicate balance between hydrodynamic and magnetic forces in the
vessel, it is crucial to choose an accurate model for blood behaviour. Moreover, the correct
size for superparamagnetic nanoparticles is used, that is ≈ 30nm in diameter, which affects
the strength of the magnetic field needed and the effects given by the diffusion contribution.
The first part of this chapter describes the non-Newtonian behaviour of blood and the
importance of choosing the right model for the viscosity and the velocity of the fluid.
Newtonian approximations are inaccurate and the more commonly used power–law model
also has a critical unbounded value for the viscosity at the center of the vessel. The
Carreau and the Ellis model are found to be the best approach to simulate blood
behaviour. While the first one is able to capture the shear-thinning behaviour of the fluid
in both Newtonian plateaux and in the transition region between them, the second one
allows to find an analytical solution for particular choices of the geometry.
Secondly, the solutions for the flow are used to model the motion of the particles.
In order to reduce agglomeration and toxicity levels, superparamagnetic nanoparticles are
found to be good candidates, since they reduce their magnetism as soon as the magnetic
field is turned off. It is also shown that, since magnetic forces scale with volume, a stronger
magnetic field is needed with respect to the microscale to overcome the drag force of the
blood. Moreover, at the nanoscale the Brownian motion and the shear-induced diffusion
can be important in the proximity of the vessel’s wall. The main result demonstrated
that the approximations made by the different models for the blood flow strongly affect
the simulation for the concentration. In fact, under the influence of the same external
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magnetic field, while the Newtonian model predicted the movement of the particle from the
bloodstream into the tissue, both the Carreau and the Ellis model showed that the strength
of the magnetic force generated was not able to attract particles to the wall of the vessel.
In future work this theoretical model can be improved including for example pulsatile
flow, the elasticity of the vessels due to the change in pressure and more realistic geometries.
Furthermore, it can be combined with detailed experimental studies to optimize the deliver
of drugs to specific regions or other applications.
6 | Conclusions
The goal of this thesis was to analyse two innovative processes in the developing field of
nanotechnology. In the first part, the growth of nanoparticles by precipitation has been
deeply studied, identifying the main features of the process in order to avoid Ostwald
ripening and optimise the growth. In the second part of the thesis, we focused on a practical
applications in nanomedicine namely magnetic drug targeting and how the non-Newtonian
characteristics of the blood are found to be key to correctly modelling this medical technique.
Like many industrial applications, the growth of nanoparticles in solution can be
modelled by means of a so-called moving boundary value problem, where the evolution of
the radius of the particles depends on time and has to be found as a part of the solution.
In particular, at the nanoscale the variation in solubility in the current problem varies in a
similar manner to the behaviour of the melt temperature in the classical applications of
this kind of problems. In the first part of the thesis the idea was to identify the key
features of the growth of a single particle and then extend these results to solve the full
problem.
In Chapter 3 we analysed the growth of a single, spherical crystal in solution. The
main aim was to correctly interpret the governing equations of the process in order to
optimise the growth. We found that the standard model was applied incorrectly over the
years, for more than one reason. First of all, the particle growth occurs in two distinct
stages and the standard model holds only during the second one. The common procedure
to fit experimental data from the very beginning of the synthesis leads to incorrect values
for the parameters of the system. Secondly, we found via mathematical tools that the
model is not able to distinguish between diffusion and surface kinetics driven growth, within
the assumptions of the pseudo-steady state. This has also been possible thanks to the
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identification of an approximate explicit solution for the particle radius, a new easy tool
not previously presented in literature. This solution only depends on two independent
parameters strongly reducing the errors in the fitting process. The importance of the particle
solubility is also demonstrated. The Gibbs-Thompson equation gives the variation of the
particle solubility with the radius rp and this contribution is generally neglected based on the
assumption that the capillary length α rp. However, since α is of the order nanometres,
at early times it is bigger than the particle radius, and therefore plays a controlling role
in particle growth at that stage. This effect has not been spotted before in the growth of
a single particle due to the fact that the model is not valid at early times but it gives an
important contribution when considering the growth of a group of particles.
The important role of the solubility in a system of particles has been widely
demonstrated in Chapter 4. It was found crucial in order to control the phenomenon
known as Ostwald ripening, where larger particles grow at the expense of smaller ones,
and to optimise the growth process. A model for the growth of N particles was developed
and dominant terms of the system were identified. The basis of this model is found in the
pseudo-steady approximation, already used in the model for the growth of a single particle
and based on the fact that the concentration adjusts much faster than growth occurs.
However, the problem is still time-dependent due to the definition of the particle radius
and the bulk concentration. The Ostwald-Freundlich condition shows how the particle
solubility s increases as size decreases and, when this value crosses the curve of the bulk
concentration cb, Ostwald ripening is observed. In fact, when s < cb then monomer
molecules diffuse from the bulk towards the particle to react with the surface and the
particle grows, whereas if s > cb the particle shrinks. Simulations with N = 2, which may
represent an initially bimodal distribution, clearly showed the role played by the changes
in solubility. As the process starts both values for the solubility are below the bulk
concentration and decrease as each rp increases, but when the solubility of the smaller
particle crosses the cb curve, its size decreases and Ostwald ripening occurs. This extended
model is able to predict in which range of parameters this undesired phenomenon can be
avoided. Moreover, making N arbitrarily large, the prediction of the particles size
distribution showed excellent agreement with experimental data and with the analytical
solution for the mean radius of the group of particles.
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As extensively highlighted in the first part of this thesis, the ability to control the
particles growth is crucial in a wide variety of industrial applications. Considering the
particular application in cancer therapy, nanotechnology-based approaches strongly rely on
precise sizes of the particles, depending on the technique developed and the unique biological
characteristics of each patient. The main aim of the second part of the thesis was to show
the great potential of the nanoscale contribution in cancer treatments and the importance
of a mathematical approximation when modelling such a delicate biological situation.
In Chapter 5 a mathematical model for the movement of drug nanocarriers in human
vessels under the influence of an external magnetic field was analysed. The main results
involved the solution of Navier-Stokes equations for the blood flow by means of geometry
simplifications and the approximation of the advection-diffusion equation for the
concentration of particles in the bloodstream via numerical techniques. The comparison
between four different models for the behaviour of the blood showed the importance of
including the variation of the viscosity, since the velocity of the particles in the vessel
strongly depends on it. Among the non-Newtonian models for the blood flow, the power
law approximation, the Carreau and the Ellis models have been used and discussed. While
the first one showed a criticality at the center of the vessel where the viscosity goes to
infinity as γ˙ → 0, the other two models were found to be both good approximations. In
particular, the Carreau model was found to be very accurate to predict the shear-thinning
behaviour of the blood, while the Ellis model is unable to capture the second Newtonian
plateaux, typical of this kind of fluids. However, since very high value of the shear rates
are not reached in our situation, their approximation are quite similar and the Ellis model
is preferred due to the possibility to write down an analytical solution for the flow in our
simplified geometry. Finally, the behaviour of the concentration of drugs bound to
magnetic nanoparticles was studied comparing the results obtained for the fluid.
Particular attention has been paid to correctly identify all the acting forces on the system
at this scale, which include the diffusive contributions given by both Brownian motion and
the scattering diffusion induced by the collisions of red blood cells, and the delicate
balance between the drag and the magnetic force needed in order to successfully attract
particles to the disease area. The identification of the dominant force strongly depends on
the position of the particles in the vessel. In the center of the stream the drag of the blood
112 Chapter 6. Conclusions
generally prevails over the magnetic forces but, as soon as we approach the wall of the
vessel, the external magnetic field is able to compete with the fluid flow, attracting the
particles to the desired region. Ideally, once they have reached the wall, particles
extravasate from the blood vessel to the tissue through the leaky vasculature and release
the therapeutic agent. However, we found that, if the approximation of the flow of blood
does not take into account its shear-thinning behaviour, the model can lead to wrong
conclusion regarding whether the particles are able to reach the disease region or not.
In summary, we have presented two mathematical models to study the features and
the applications of nanotechnology in real-life problems. The main goal was to show how
mathematical-based approaches are required to fully understand and optimise physical,
chemical and biological processes, allowing to make several steps forward even in the fight
against cancer.
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